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ABSTRACT 
Natural antimicrobials from plant, animal, or microbial sources have the potential to 
increase food safety, improve shelf life and promote the idea of “natural foods.” The overall 
objective of this research was divided into two parts. The aim of the first part was to evaluate 
the antimicrobial efficacy of phenyllactic acid alone or in combination with phosvitin against 
four human enteric pathogens. The aim of the second part was to evaluate the efficacy of 
phenyllactic acid (PLA) against selected mold species. Growth inhibition of Listeria 
monocytogenes, Salmonella enterica, Staphylococcus aureus, or Escherichia coli O157:H7 
by PLA  used singly or combined with phosvitin in brain heart infusion (BHI) broth (35 °C) 
was evaluated over a 24-hour period using a Bioscreen C Turbidometer (OD 600nm). 
Subsequently, selected concentrations of the antimicrobials were evaluated for their 
antimicrobial effectiveness in controlling growth of the pathogenic bacteria in cream of 
chicken soup at 12 ºC and 35 ºC. Growth inhibition of Aspergillus ochraceus, Aspergillus 
spp, Penicillium roqueforti, Penicillium glabrum, and Penicillium spp. by phenyllactic acid 
in brain heart infusion (BHI) broth (25 °C) was also evaluated over a 5-day period using a 
Bioscreen C Turbidometer (OD 600nm).  
In cream of chicken soup, at both temperatures, phenyllactic acid (5 mg ml-1) alone 
exerted the greatest bactericidal effect against all four pathogens throughout storage. At 12 
°C and 35 °C, phosvitin combined with PLA (3.75 or 5 mg ml-1) did not offer enhanced 
antibacterial effect above that provided by PLA (5 mg ml-1) used alone. PLA had the greatest 
growth inhibitory effect on all the mold species at the lowest pH tested (pH 3.8). The 
minimum inhibitory concentration (MIC) of PLA at pH 3.8 against all the mold species was 
vi 
 
15 mg ml-1. Based on results of the present studies it is concluded that: i) PLA (5 mg ml-1) 
has good potential for controlling the growth of foodborne pathogenic bacteria in cream of 
chicken soup and ensuring the microbial safety of this potentially hazardous food product, ii) 
PLA and phosvitin combinations are far less effective for inhibiting growth of pathogens in 
soup, iii) PLA has the potential to control Penicillium and Aspergillus molds if used in an 
acidic environment. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Foodborne diseases are a growing health problem worldwide. In 2005, the World 
Health Organization estimated that 1.8 million people died from foodborne related diseases. 
The Centers for Disease Control estimates that every year 48 million Americans (1 in every 6 
persons) contract a foodborne illness, 128,000 are hospitalized, and 3,000 die. A majority 
(90%) of the annual cost of foodborne illness in the United States ($12.6 billion dollars) is 
attributed to 5 pathogens namely, Salmonella enterica, Campylobacter spp., Listeria 
monocytogenes, Toxoplasma gondii, and norovirus (Hoffman et al., 2012). While it is 
completely impossible to exterminate foodborne pathogens, the government, food processors 
and manufacturers, and retailers should take an active role in trying to ensure foodborne 
diseases are kept to a minimum.    
Green consumerism,  a consumer-driven effort to replace synthetic additives in food 
products with more natural ingredients, has been a topic of discussion for an extended period 
of time, but recently it has gained a vast amount of interest due to consumer demands for 
reduced use of synthetic chemical preservatives in foods. Some common examples of 
traditionally used “chemical” preservatives are sorbates, sulfites, nitrites and parabens. The 
main consumer concern is the long term adverse effects that synthetic food preservatives 
might have on health. Two examples of preservatives (commonly used in the cheese 
industry) that are being re-evaluated due to their unique problems are potassium sorbate and 
natamycin. Both of these compounds are antifungal agents added to cheese. Potassium 
sorbate is the potassium salt of sorbic acid which comes from the Rowan Berry. Although 
2 
 
 
 
mold growth in cheese can be effectively inhibited by potassium sorbate, certain species of 
Aspergillus and Penicillium can degrade potassium sorbate via decarboxylation and produce 
unpleasant odors (Marth et al., 1966; Sofos and Busta, 1981; Kinderlerer and Hatton, 1990). 
Due to the fact that Aspergillus and Penicillium can metabolize potassium sorbate, natamycin 
is relied on to control mold growth in cheese. Natamycin is considered as an antibiotic 
polyene that is quite effective against yeast and molds but not bacteria. Natamycin is 
produced by Streptomyces natalensis and has been accepted by the Food and Agriculture 
Organization/the World Health Organization (FAO/WHO) as a food preservative because it 
stimulates an unusually low level of resistance among fungi, it is rarely involved in cross-
resistance among other antifungal polyenes, and DNA transfer of resistance genes between 
fungi does not occur to the extent as observed in some bacteria (Jay et al., 2005). The 
effectiveness of natamycin in cheese is limited by the fact that it has relatively poor 
solubility, distribution, and stability. In addition to being an antifungal in cheese, natamycin 
is also used to treat fungal infections including, Candida, Aspergillus, Fusarium, and 
Penicillium. While using potassium sorbate and natamycin does indeed inhibit mold growth 
in cheese, the need for natural additives as replacements for these antifungal agents is still 
prevalent.   
An alternative replacement to synthetic preservatives in foods is natural preservatives 
from plant, animal, or microbial sources. Eggs from poultry contain numerous proteins that 
have antimicrobial properties. An egg yolk protein of interest is phosvitin. Phosvitin is a 
phosphoglycoprotein that has the ability to bind multivalent metals such as Fe2+, Ca2+, and 
Mg2+ (Grogan and Taborsky, 1987). By binding metal ions in the microorganism’s 
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environment, phosvitin may inhibit microbial growth or by binding metal ions that stabilize 
the outer membrane of Gram-negative bacteria, it might be able to disrupt bacterial cells 
(Satter Khan et al., 2000). 
Currently there are many food preservation technologies and techniques, but most of 
them involve the use of synthetic chemical preservatives, high amounts of energy, or 
substantial cost. A new emerging technique involves using lactic acid bacteria (LAB) and 
their metabolites to preserve food. Lactic acid bacteria have been granted Generally 
Recognized as Safe (GRAS) status, due to their long tradition of being consumed in dairy 
products and their contribution to healthy intestinal microflora in humans, so the interest in 
using them as a biopreservative has increased (Valerio et al., 2004). In addition to acid 
production, lactic acid bacteria can also produce bacteriocins. Bacteriocins are antibacterial 
proteins that kill or inhibit the growth of other bacteria (Cleveland et al. 2001). The most 
well-known bacteriocin is Nisin. Nisin produced by Lactococcus lactis has a broad spectrum 
of activity against gram-positive bacteria and is generally recognized as safe (GRAS) in the 
United States for use in selected pasteurized cheese spreads to control the outgrowth and 
toxin production of Clostridium botulinum (Stevens et al., 1991). Nisin is a special 
bacteriocin because it is effective against gram-positive organisms including, but not limited 
to, lactic acid bacteria and Listeria monocytogenes. Nisin is also nontoxic, produced by 
Lactococcus lactis, is destroyed by digestive enzymes and does not contribute to off-flavors 
or off-odors (Jay et al., 2005). In addition to bacteriocins, several other compounds with 
strong antifungal activity have been isolated from bacterial cultures. Currently, the majority 
of identified antifungal substances are low molecular weight compounds. Some of those 
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compounds are of organic acids, reuterin, hydrogen peroxide, proteinaceous compounds, 
hydroxyl fatty acids and phenolic compounds (Dalie et al, 2009).  Research has shown that 
some compounds isolated from lactic acid bacteria can have an inhibitory effect on either 
bacteria or yeasts and molds.    
 The combination of natural antimicrobials could possibly lead to an enhanced 
inhibitory effect of the antimicrobials against foodborne pathogens as opposed to an 
antimicrobial being used separately. Additive or synergistic effects between the natural 
antimicrobials could allow the use of lower quantities of each antimicrobial and substantially 
reduce the cost of each treatment while still improving the efficiency of the antimicrobial to 
control pathogens. 
Thesis Organization 
 This thesis is divided into five chapters. The first chapter is comprised of a general 
introduction. The second chapter is a literature review that contains information that is 
pertinent to the research performed in chapters 3 and 4. The final chapter (Chapter 5) is a 
general conclusion based research findings that are stated in chapters 3 and 4. All relevant 
tables and figures appear at the end of their respective paper, which follows a specified 
journal format. References are located at the end of each chapter with formatting following 
journal specifications. Chapter 3 is intended to be submitted to the scientific journal, Food 
Microbiology, and Chapter 4 is intended to also be submitted to Food Microbiology. The 
abstract titled “Antibacterial Effectiveness of Phenyllactic Acid against Gram-positive and 
Gram-negative foodborne pathogens at pH 6.0 and 7.2” was presented in a poster format at 
the annual meeting of the International Association for Food Protection in Providence, Rhode 
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Island (July 2012). The abstract titled “The Antimicrobial Efficacy of DL-3-Phenyllactic 
Acid against selected Aspergillus and Penicillium molds at 25 °C” was presented in a poster 
format at the annual meeting of the Institute of Food Technologists in Las Vegas, Nevada 
(June 2012).  
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CHAPTER 2. LITERATURE REVIEW 
Phenyllactic Acid 
Phenyllactic acid (PLA) is an antimicrobial compound isolated from Geotrichum 
candidum as well as from several Lactobacillus species. It was originally used to inhibit L. 
monocytogenes in milk (Dieuleveux and Gueguen 1998). PLA is active against Gram 
positive bacteria, Gram negative bacteria, and fungi. PLA has also been found in honey at 
concentrations ranging from 100-800 mg/kg (Mu et al. 2012). It has also been found in high 
concentrations in heather (820 mg/kg), ling heather (875 mg/kg), and manuka honeys (243 
mg/kg) (Tan et al. 1988; Dimitrova et al. 2007). More recently the use of lactic acid bacteria 
(isolated from sourdough bread) to inhibit mold growth has been evaluated. This has led to 
the discovery that Lactobacillus plantarum 21B produces PLA (Lavermicocca et al., 2000; 
Lavermicocca et al., 2003). It has also been discovered that PLA may be present in some 
fermented foods (including sourdough bread) that use LAB as a starter culture (Van der 
Meulen et al. 2007; Ryan et al. 2009).  PLA is a novel antimicrobial compound and much 
research still needs to be conducted to discover its full antimicrobial capabilities. 
Chemical Structure and Forms 
The molecular formula of PLA is C9H10O3 and its molecular weight is 166 g/mol. 
This antimicrobial has four main forms, D-3-phenyllactic acid, L-3-phenyllactic acid, DL-3-
phenyllactic acid, and 4-hydroxyphenyllactic acid, all of which are produced by specific 
strains of either Geotrichum candidum or Lactobacillus. Limited research has been 
conducted on all four forms, but DL-3-phenyllactic acid and 4-hydroxyphenyllactic acid have 
the greatest antifungal effect, and also have an antibacterial effect against L. monocytogenes, 
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Staphylococcus aureus, and Escherichia coli O157:H7 (Dalie et al, 2009; Schwenninger et 
al. 2008; Ohhira et al. 2004; Lavermicocca et al. 2003; Lavermicocca et al. 2000, Dieuleveux 
et al. 1998).  
Influence of pH 
DL-3-Phenyllactic acid was evaluated against Aspergillus niger FTDC3227 using 
five different pH values (2.6, 4.0, 4.5, 5.0, and 5.5).  At pH 2.6, the greatest antifungal effect 
was observed in that mold species, whereas, in Penicillium and other Aspergillus species, the 
greatest effect occurred at pH 5.5. At a pH of 4.0, a value close to the pH values in several 
food systems, and commonly attained in the culture filtrate of lactic acid bacteria, a slight 
reduction in phenyllactic acid was observed (Lavermicocca et al. 2003). The activity of PLA 
is pH dependent, indicating that its mode of action is related to the lipophilic properties 
which enable the undissociated form of that organic acid to cross the microbial membrane 
and acidify the interior environment of microbial cells (Gould, 1996).  
Inhibitory effect of PLA in the presence of other organic acids 
The combined effect of PLA with other organic acids such as lactic acid and/or acetic 
acid was evaluated in solution against A. niger FTDC3227 at a PLA concentration of 5 mg 
ml-1 (Lavermicocca et al. 2003). Lactic acid alone at a concentration of 15.8 mg ml-1 
exhibited a 33% inhibitory effect against that mold.  When applied at that same concentration 
in combination with PLA (5 mg ml -1), lactic acid caused a 30% increase in PLA’s inhibitory 
activity (from 53 to 82%). Acetic acid alone at a concentration of 0.67 mg ml-1 produced a 
7% inhibitory effect against A. niger FTDC3227 whereas, when applied in combination with 
PLA, increased the antifungal activity of PLA by 18%. Those same researchers demonstrated 
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that when PLA, lactic acid, and acetic acid are combined, the greatest percent inhibition 
against A. niger FTDC3227 is 83%.   
Antibacterial activity 
The antibacterial activity of PLA was first reported by Dieuleveux et al. (1998). It 
was discovered that Geotrichum candidum produces and secretes phenyllactic acid and 
indolelactic acid, both of which have anti-Listeria activity. Phenyllactic acid in milk, cheese, 
and cultured medium was shown to inhibit the growth of Listeria monocytogenes. In ultra-
high temperature (UHT) processed milk, phenyllactic acid exhibited a bacteriostatic effect on 
Listeria monocytogenes at 7 mg ml-1 over 5 days compared to the control (Dieuleveux and 
Gueguen, 1996).  
 Apart from its ability to inhibit Listeria monocytogenes, PLA can also inhibit other 
Gram-positive bacteria such as Staphylococcus aureus, Enterococcus faecalis, and Bacillus 
cereus as well as gram-negative bacteria, such as Salmonella enterica, Escherichia coli, 
Providencia stuartii, and Klebsiella oxytoca (Dieuleveux et al., 1998, Ohhira et al. 2004). 
The antibacterial action of PLA is has not been completely elucidated but it has been 
suggested that the site of action could be the bacterial cell wall. Bacterial cells exposed to 
PLA exhibited damaged or completely altered cell walls. Bacteria grown in 7 mg ml-1 PLA 
had broken cell wall openings along the length of the cell which allowed efflux of cellular 
constituents (Dieuleveux et al., 1998). 
Antifungal Activity 
 In addition to its antibacterial action, PLA has the capability to inhibit yeast and 
molds as well. Schwenninger et al. (2008) demonstrated that PLA is effective against 
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Rhodotorula mucilaginosa, Candida pulcherrima, and Candida parapsilosis and 
Lavermicocca et al. (2000) demonstrated that PLA is effective against molds isolated from 
bakery products, flour, and cereal including Aspergillus ochraceus and Penicillium 
roqueforti. For anti-yeast activity, PLA has a relatively high minimum inhibitory 
concentration ranging from 50 to more than 500 mM at pH 4.0 to 6.0 and as the pH decreases 
the minimum inhibitory concentration decreases (Schwenninger et al., 2008). The minimum 
inhibitory concentration of PLA for mold at pH 4.0 is 45 mM (Strom et al., 2002).  
 Lavermicocca et al. (2000) first characterized and also purified PLA from the 
antifungal compounds produced by Lactobacillus plantarum 21B. The growth of mold in 
sourdough bread fermentation can be delayed up to seven days if Lactobacillus plantarum 
21B is used as a starter culture (Lavermicocca et al. 2000). According to Valerio et al. (2004) 
the extent of the antifungal activity of lactic acid bacteria strains such as Lactobacillus 
plantarum 21B was positively related to the metabolic content of phenyllactic acid.  
Phosvitin 
Composition 
 Phosvitin, a phosphoglycoprotein isolated in 1949 from the egg yolk of hens, contains 
a high amount of phosphorus and accounts for 60% of total egg yolk phosphoproteins 
(Mecham and Olcott, 1949). Phosvitin has an amino acid composition of 50% serine, and 
90% of which are phosphorylated (Mecham and Olcott, 1949; Clark, 1985). It contains 216 
amino acids of which 123 are serines (Fig 1; White, 2011; Byrne et al., 1984; Clark, 1985). 
The molecular weight of phosvitin ranges from 36 to 60 kDa and the major component is B-
phosvitin which has a molecular weight of 45 kDa (Abe et al., 1982). Phosvitin contains 
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12.3% nitrogen, 10% phosphorus (80% of yolk protein phosphorus), and 6.5% nitrogen 
(Taborsky and Mok, 1967; Xu et al., 2007; Samaraweera et al., 2011). This protein is one of 
the most highly phosphorylated proteins in nature, and has been used as a phosphoprotein 
standard (Ilg et al., 1996).  
Figure 1. Amino acid sequence of hen egg yolk phosvitin. (Source: White 2011; Byrne et 
al. 1984; Clark 1985). 
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Extraction, isolation, and purification 
The methods described by Mecham and Olcott (1949) to extract and isolate phosvitin 
in 1949 are most commonly used. Generally, methods for purifying phosvitin consist of an 
isolation phase and a fractionation via hydrophobic interaction and ion-exchange 
chromatography (Castellani et al., 2003). Fractionation via chromatography helps to purify 
phosvitin and/or separate different phosvitin polypeptides (Mecham and Olcott, 1949; Sim 
and Nakai, 1994; Sundararajan et al., 1960; Joubert and Cook, 1958; Wallace and Morgan, 
1986). The production methods for phosvitin are limited because most of the methods 
associated with preparation, extraction, and isolation use chemicals that are non-aqueous or 
are not food-grade (Wallace and Morgan, 1986; Castellani et al., 2003). A sodium chloride 
extraction method has been shown to be successful and selective in isolating phosvitin from 
whole egg yolk (Choi et al., 2005). The cost of phosvitin is relatively high due to the methods 
needed to extract and purify this protein. The cost of phosvitin is $1,225.00 per gram based 
on the current price listed in the Sigma-Aldrich 2012 catalog. More recently, a water/ethanol 
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based method, developed by researchers at Iowa State University, permits an efficient and 
cost effective option for extraction and purification of phosvitin from hens’ egg yolk (White, 
2011). 
Structure 
Phosvitin is largely hydrophilic and has a high number of negative charges and a low 
percentage of nonpolar hydrophobic side chains (Dickinson et al., 1997). Phosvitin can 
behave as a polyelectrolyte in liquid state due to high phosphoric acid bound to serine 
residues (Grizzuti and Perlmann, 1970). It is composed of 66% acidic, 16% basic, and 18% 
nonpolar amino acids. The amino acid sequence contains 216 amino acids composed of 123 
serines (S), virtually all of which are phosphorylated, 15 lysines (K), 13 histidines (H), and 
11 arginines (R) (Byrne et al., 1984). The structure of the peptide groups in the protein chain 
of phosvitin may be characterized as containing (a) very little α-helix conformation, (b) a 
minority of residues in β-sheet and/or irregular conformations, and (c) a majority of residues 
in an unusual conformation (Prescott et al., 1986). At near a neutral pH, phosvitin has an 
irregular structure, whereas at an acidic pH, phosvitin has a β-sheet structure (Taborsky, 
1970; Perlmann & Grizzuti, 1971). 
Stability 
Phosvitin is heat resistant as first reported by Mecham and Olcott (1949). When 
heated for several hours at 100°C from pH 4 to 8, phosvitin solutions did not show any sign 
of denaturation (Mecham and Olcott, 1949). In an electropherogram, phosvitin bands were 
completely diffused after heating at 140°C for 10 minutes; however, at 100°C for 10 minutes 
no change in the electrophoretic profile was observed (Itoh et al., 1983). In addition, high 
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pressures up to 600 MPa do not disrupt phosvitin’s stability (Castellani et al., 2004). 
Phosvitin is not easily digested by pepsin, trypsin, and chymotrypsin (White, 2011). After 
enzymatic digestion, the negative charge of the phosphate group makes the neighboring 
peptide bonds resistant to proteolytic action while keeping the protein core together (Goulas 
et al., 1996).  
Antimicrobial properties 
To our knowledge, there is only one published study on the antibacterial potential of 
phosvitin to date,   In that same study, phosvitin, protease-digested phosvitin, and phosvitin-
galactomannan conjugate were evaluated against Escherichia coli under thermal stress at 
50°C (Satter Khan et al., 2000). Those authors reported that phosvitin and phosvitin-
galactomanna conjugate were significantly more effective in decreasing the viability of 
Escherichia coli in L-broth at 50°C for 20 minutes, whereas, protease-digested phosvitin was 
not effective. The antibacterial activity of phosvitin is believed to be attributed to the 
chelating properties of its phosphate groups linked to removal of cations such as magnesium 
and calcium that stabilize the outer membrane of Gram-negative bacteria. In conjunction 
with thermal stress, these properties seem to induce the decrease in viability of Escherichia 
coli (Satter Khan et al., 2000). 
Listeria monocytogenes 
Morphology and Growth Characteristics 
Listeria monocytogenes is a Gram-positive, non-sporeforming, regular rod-shaped 
bacterium that is catalase positive and oxidase negative. This bacterium is a psychrotrophic, 
facultative anaerobe that usually occurs in single or short chains and grows rapidly at 7°C-
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10°C. When Listeria monocytogenes is grown between 20 and 25°C, flagellin is both 
produced and assembled at the cell surface, but at 37°C, flagellin production is reduced (Peel 
et al., 1988) The Listeria genus is composed of eight different species including L. grayi, L. 
seeligeri, L.welshimeri, L. ivanovii, L. innocua, L. monocytogenes, and the more recently 
identified, L. marthii and L. rocourtiae (Graves et al., 2010; Leclercq et al., 2010). Listeria 
monocytogenes has been categorized into several serotypes: 1/2a, 1/2b, 1/2c, 3a, 3b, 3c, and 
4a, 4ab, 4b, 4c, 4d, 4e (Seeliger, 1958; Donker-Voet, 1972). Although all serotypes are 
capable of causing disease in humans, 95 to 98% of listeriosis cases documented in humans 
are attributed to serotypes 1/2a, 1/2b and 4b (Lund et al., 2000),   
The optimal growth temperature for L. monocytogenes is 35°C to 37°C but the 
pathogen  is also able to grow at temperatures ranging from 1.5°C to 45°C (Juntilla et al., 
1988; Vasseur et al., 1999). This organism is capable of growing at a pH range of 4.5 and 9.6 
(Seelinger and Jones 1986). Between pH 6.0 and 8.0 L. monocytogenes can reach its highest 
final population in the absence of growth-limiting factors (Buchanan et al., 1994; Petran and 
Zottola 1989; Ryser and Marth 1988). L. monocytogenes is also capable of tolerating salt and 
nitrite as well as a water activity of less than 0.93 (McClure et al., 1997; Farber et al., 1992). 
The lowest water activity values allowing growth to > 6.5 log CFU ml-1 in presence of 
glycerol, sucrose, NaCl, and propylene glycol were 0.90, 0.92, 0.92, and 0.97, respectively 
(Miller, 1992; Nolan et al., 1992) L. monocytogenes is destroyed by conventional thermal 
processing of foods at temperatures above 56°C due to irreversible cellular damage which 
results in the death of the organism (Bunduki et al., 1995). 
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Contamination sources 
 Listeria monocytogenes is widely located in plant, soil, silage, sewage, slaughter 
house waste, human and animal feces, processing environments, and catering facilities 
(Farber and Peterkin 1991; Beresford and others 2001). Soils containing dead or decaying 
vegetation and/or fertilized with animal feces or sewage sludge, can harbor L. 
monocytogenes. Listeria monocytogenes was not detected on standing grass but instead was 
detected 24 hours later on grass samples that had been cut and started to decay. Further 
investigation led to the interesting discovery that a natural habitat for L.monocytogenes is 
decaying grass or silage which is easily a source of listeriosis for farm animals (Fenlon et al., 
1995). 
 Foods that have been associated with contamination of L. monocytogenes include: 
soft cheese, raw milk, ice cream/soft cream, butter, cooked chicken, turkey frankfurters, 
sausages, pate and rillettes, pork tongue in aspic, fish, shellfish, shrimp, smoked fish, cod roe, 
coleslaw salad, vegetable rennet, salted mushrooms, raw vegetables, pickled olives, rice 
salad, cut fruit, and cold sandwiches (Wagner and McLauchlin, 2008). 
 Not only can L. monocytogenes adhere to food and soil surfaces but it is also capable 
of readily adhering to the surfaces of food processing benches, machinery, and floors.  
Following attachment to surfaces, the pathogen can subsequently produce a biofilm matrix 
which increases the pathogen’s resistance to adverse conditions (Blackmann and Frank, 
1996). More specifically, L. monocytogenes serotypes 1/2a, 1/2b, and 1/2c appear to have 
better adapted to meat processing plants, as they have more often been isolated more often 
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from these particular environments (Jay, 1996; Norwood and Gilmour, 2000; Autio et al., 
2002). 
Listeriosis outbreaks in foods 
 Listeria monocytogenes was first described as a pathogen in the 1920s (Low and 
Donachie, 1997) and listeriosis was initially recognized as a disease of animals. It was not 
until the 1980s that L. monocytogenes was recognized as a foodborne human enteric 
pathogen. In 1981, an outbreak involving the consumption of coleslaw containing L. 
monocytogenes serotype 4b resulted in 41 reported cases of listeriosis (34 perinatal and 7 
adult) (Farber and Peterkin, 1991). Of the 34 infected patients, 9 had stillbirths and 23 had 
infected infants with a 27% mortality rate and 2 live births of a well infant. In 1983, in the 
state of Massachusetts, pasteurized milk was contaminated with L monocytogenes type 4b. 
This contamination resulted in 49 (7 perinatal and 42 immuno-compromised individuals) 
cases of listeriosis and 14 deaths (Fleming et al. 1985). In 1985, a listeriosis outbreak in 
California was linked to contaminated Jalisco cheese due to the presence of L. 
monocytogenes type 4b. Of 142 cases, 93 were perinatal, 49 were non-pregnant, 48 were 
immuno-comprosed individuals and 48 individuals died (Linnan et al., 1988). 
 More recently listeriosis in humans was linked to fresh produce. In 2011, there was a 
multistate outbreak of listeriosis associated with cantaloupes from Jensen Farms located in 
Colorado. Illnesses totaled 147 along with 33 deaths across 28 states (CDC, 2011). The most 
recent multistate outbreak of listeriosis has been attributed to contamination of ricotta salata 
cheese from the brand Frescolina Marte. For the outbreak, 18 cases have been reported across 
13 states along with 18 hospitalizations and 3 deaths (CDC, 2012).  
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Characteristics of listeriosis  
 Listeriosis occurs in a variety of animals, including humans, and the disease most 
often affects the uterus at pregnancy, the central nervous system, or the bloodstream (Wagner 
and McLauchlin, 2008). Almost all cases of human listeriosis are attributed to L. 
monocytogenes (McLauchlin, 1997). Rarely are human listeriosis infections caused by 
Listeria ivanovii and Listeria seeligeri (Rocourt et al., 1986; Cummins et al., 1994). 
Listeriosis most often affects individuals that are immuno-compromised, including the 
elderly, pregnant women, and unborn or newly delivered babies. Infection can be treated with 
antibiotics, but yet human infection has a mortality rate of 20-40% (Farber and Peterkin, 
1991). 
Several factors increase the risk of listeriosis such as: contamination of raw product 
or factory sites, cross contamination from other foods, persistence of the pathogen in the food 
chain, adaptation of virulent strains to certain environmental stresses, poor processing, 
retailing, and storage of food, and incomplete surveillance. These risks can be decreased by 
excluding L. monocytogenes from the food chain by adequate temperature and shelf-life 
control,  environmental hygiene, increased quality of raw materials, implementation of 
HACCP process controls, guidelines, standards, food regulation, education of all those 
involved with the food chain, surveillance of clinical cases and foods, and withdrawal of 
contaminated foods. Those foods linked to listeriosis outbreaks generally have the following 
common features: i) capable of supporting the multiplication of L. monocytogenes, ii) 
processed with extended (usually refrigerated) shelf lives, iii) consumed without further 
cooking, and iv) contaminated with high levels of L. monocytogenes (McLauchlin, 1996). 
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Salmonella enterica 
Morphology and growth characteristics 
Salmonella is a rod shaped, gram-negative, non-spore-forming, facultative anaerobe 
belonging to the Enterobacteriaceae family (Hammack, 2012). Based on the most recent 
nomenclature, Salmonella can be divided into two species, Salmonella bongori and 
Salmonella enterica (S. enterica). Within Salmonella enterica are six subspecies: S. enterica 
subsp. enterica (I), S. enterica subsp. salamae (II), S. enterica subsp. arizonae (IIIa), S. 
enterica subsp. diarizonae (IIIb), and S. enterica subsp. houtenae (IV), S. enterica subsp. 
indica (VI) (Hammack 2012). Salmonella enterica has over 2500 identified serovars that 
belong to six subspecies (Ochman and Groisman, 1994; Fierer and Guiney, 2001).  
Salmonella has the ability to grow under various environmental conditions. Sodium 
chloride (NaCl) is not required for growth, but in the presence of 0.4 to 4% NaCl Salmonella 
is still able to grow. Most serotypes of Salmonella are able to grow at a temperature range of 
5 to 47°C with an optimum growth temperature of 35 to 37°C. Some can even grow slowly at 
temperatures as low as 2 to 4°C or as high as 54°C (Gray and Fedorka-Cray, 2002) if other 
intrinsic and extrinsic factors such as pH, water activity, oxidation-reduction potential, and 
gaseous atmosphere are optimum for the pathogen. Salmonella is sensitive to heat and often 
killed at temperature of 70°C or above. This pathogen can grow at a water activity (aw) 
between 0.99 and 0.94 and survive at aw <0.2 in several dried food products. At temperatures 
of <7 ºC, pH <3.8, or water activity <0.94 complete inhibition is observed (Hanes, 2003; 
Bhunia, 2008).   
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Contamination sources  
 Salmonella is quite prevalent in the environment and this occurrence is most likely 
linked to several animal reservoirs of this pathogen. Salmonella can colonize the intestinal 
tracts of vertebrates, including livestock, wildlife, domestic pets, and humans (Hammock, 
2012). Salmonella serotypes such as S. Typhi and S. Paratyphi are only found in humans 
(Miller and Pegues, 2005). Salmonella transmission has originally been linked to poultry, 
eggs and dairy products, but more and more it has been associated with reptiles such as pet 
tortoises, snakes, iguanas, frogs, and aquatic turtles (Bouchrif et al., 2009, CDC, 2003; 
Mermin et al. 1997). More recently, fresh produce such as fruits and vegetables have been 
implicated as transmission sources of Salmonella (Bouchrif et al., 2009). Salmonella 
contamination of fresh produce could be due to the entry of Salmonella through scar tissues, 
entrapment during embryogenesis of produce, natural uptake through root systems and 
transfer onto edible plant tissues during slicing. A major factor that is contributing to the 
prevalence of Salmonella in fresh produce is the increased importation of fresh fruits and 
vegetables from countries that have a climate that is suitable to grow these products year 
round. Hygienic conditions in those countries during production, harvesting, packaging, and 
distribution of fresh produce may not meet minimum U.S. standards. These sub-standard 
hygienic conditions contribute to microbial contamination of fresh produce. In addition there 
are several other factors that can facilitate the persistence of Salmonella on fresh produce. 
These include crops that are fertilized with untreated sewage water, washing of fresh produce 
with water that has been contaminated, and improper handling of produce by field workers.  
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Salmonellosis outbreaks in foods 
Salmonella is responsible for approximately 1.4 million non-typhodial illnesses, 
15,000 hospitalizations, and 400 deaths in the US every year (CDC, 2008). Salmonella 
enterica serotype Enteritidis is one of the most common Salmonella serotypes worldwide 
predominantly in developed countries. During the 1980s, an important cause of foodborne 
human illness was attributed to S. Enteritidis (Patrick et al. 2004). According to the CDC’s 
2011(a) “Estimates for Foodborne Illness,” Salmonella ranked as one of the most 
problematic pathogen as it was responsible for an estimated 1,207,561 illnesses, 19,336 
hospitalizations, and 378 deaths. Eggs and raw or undercooked poultry are foods that are 
most usually associated with causing Salmonella infections. This trend is slowly shifting: for 
example, from 2006 to 2012, numerous serovars of Salmonella have been linked to 
contamination of other foods including: tomatoes, peanut butter, dry pet food, pot pies, 
cantaloupes, Malt-o-Meal Rice/Wheat cereals, raw produce, pistachios, alfalfa sprouts, red 
and black pepper, Italian-style meats, frozen fruit pulp, cantaloupe, turkey burgers, imported 
papayas, and mangoes (CDC, 2012a).  
In 2007, Salmonella Tennessee was involved in a large multi-state outbreak 
associated with peanut butter that caused 425 infections from 44 states, 71 hospitalizations, 
and no deaths (CDC, 2007). Salmonella Litchfield infected 51 people in an outbreak 
associated with cantaloupes imported from Honduras in 2008 (CDC, 2008a). In 2009, there 
was an outbreak of Salmonella Saintpaul associated in raw alfalfa sprouts resulting in 235 
infections from 14 states and no deaths (CDC, 2009). Another notable outbreak in 2009 was 
attributed to Salmonella Typhimurium. It was responsible for a multistate outbreak in peanut 
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butter which resulted in 714 infections in 46 states and nine deaths (CDC, 2009a). In 2010, 
Salmonella Enteritidis was responsible for contaminated eggs in Iowa. Approximately 2000 
people from 11 states suffered illness (CDC, 2010). In a more recent outbreak, Salmonella 
Typhimurium and Salmonella Newport are both responsible for 270 illnesses, 101 
hospitalizations, and 3 deaths in a multi-state outbreak in cantaloupes (CDC, 2012b).   
Characteristics of Salmonellosis 
Salmonellosis is an infection caused by Salmonella. Elderly, infants, and those with 
weak immune systems are most susceptible to salmonellosis. A majority of people that are 
infected with Salmonella develop diarrhea, fever, vomiting, and abdominal cramps 12 to 72 
hours after infection (CDC, 2010a). In addition, after bacterial infections, reactive arthritis 
(Reiters syndrome) can develop in some individuals (Dworkin et al., 2001). Reiters 
syndrome can last for months or years and usually causes pain and swelling that affects the 
ankles, knees, and feet (Colville and Berryhill, 2007). Salmonella infections often do not 
require medical treatment other than fluids taken orally and are usually resolved in 5-7 days. 
Antibiotics such as ampicillin, trimethoprim-sulfamethoxazole, or ciprofloxacin, are not 
usually necessary unless the infection spreads from the intestines (CDC, 2010). Various 
species of Salmonella have become resistant to antibiotics as a result of feeding animals, 
which will serve as food products, antibiotics to help promote growth. Not only is 
salmonellosis responsible for numerous illnesses but there is also a monetary consequence. 
Salmonella outbreaks in the United States have been estimated to range from $600 million to 
$3.6 billion dollars each year (Ter-Hsin et al., 2005).  
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Staphylococcus aureus 
Morphology and Growth Characteristics 
Staphylococcus aureus (S. aureus) is a member of the Micrococcaceae family. It is a 
Gram positive, non-spore forming facultative anaerobe and is coccus-shaped bacterium. 
Under microscopic examination, S. aureus cells are arranged in grapelike clusters.  Many of 
the 32 S. aureus species and subspecies are found in foods due to environmental, human, and 
animal contamination (Hait, 2012). S. aureus is differentiated from other staphylococcal 
species on the basis of pigmentation of colonies, coagulase reaction (coagulase positive) and 
ability to ferment mannitol (Wilkinson, 1997). Staphylococcus species that are mostly 
implicated in human infections include: S. aureus, S. saprophyticus, S. epidermidis, 
S.lugdunensis, and S. schleiferi (von Eiff et al., 2002; Choi et al., 2006; Otto, 2009). In 
regards to human foodborne illness, S. aureus is the most prevalent.  
Staphylococcus aureus strains can be divided into biotypes according to their human 
and animal origin. In 1984, Devriese developed a biotype classification system and separated 
S. aureus into human, non-β-hemolytic human, avian, bovine, ovine, and nonspecific 
biotypes. Staphylococcus aureus is capable of growing in temperatures ranging from 7 to 
48.5°C with an optimum growth temperature of 30 to 37°C (Schmitt et al., 1990). In addition 
to being able to grow in wide range of temperatures, S. aureus can also grow in a wide range 
of pH values ranging from 4.2 to 9.3 with an optimum pH of 7 to 7.5 (Bergdoll, 1989). A 
unique characteristic of S. aureus is its ability to grow in salt concentrations as high as 15%. 
The optimum water activity for S. aureus is about 0.99 but it is also capable of growing at 
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water activities as low as 0.83 (Hait, 2012) if other intrinsic and extrinsic factors are optimal 
for growth of this pathogen 
Contamination sources 
 Staphylococcus aureus is frequently found among the microbial flora on human skin 
and nasal passages (Kluytmans et al., 1997). From infected hosts, S. aureus has been isolated 
from nostrils, mouth, upper respiratory tract, mammary glands, intestinal tracts and 
genitourinary tracts (Murray et al., 1999). Up to 30-50% of the human population arecarriers 
(Le Loir, 2003). Some sources of S. aureus contamination are food handlers through manual 
contact of food products or coughing and sneezing on food products after heat treatment; 
however, equipment and environmental surfaces can also serve as contamination sources. In 
cases of human intoxication, food usually associated with an outbreak has not been kept at a 
refrigerated temperature of <10°C or has not been kept hot enough (>45°C) (Hait, 2012).   
Staphylococcus aureus outbreaks in foods 
Various foods can support growth of S. aureus and have been implicated in 
staphylococcal food poisonings and outbreaks.  Those foods include milk and cream, cream 
filled pastries, butter, ham, cheeses, sausages, canned meat, salads, cooked meals and 
sandwich fillings (Le Loir et al., 2003). In one instance, cheese was involved in an outbreak 
because it had been produced from milk contaminated after pasteurization and before 
inoculation with a lactic acid bacteria starter culture (Bergdoll, 1989). In 1985, chocolate 
milk was the source of staphylococcal poisoning due to contamination and improper storage 
for 4 to 5 hours (Le Loir et al., 2003). In 1989, S. aureus enterotoxin type A (SEA) was 
associated with multiple outbreaks of canned mushrooms (CDC, 1989). Individuals, across 3 
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states, totaling 102 contracted an illness and 12 were hospitalized. According to the Centers 
for Disease Control and Prevention’s “Estimates of Foodborne Illness for 2011(b),” S. aureus 
was responsible for approximately 241,148 cases of foodborne illness.  
Characteristics of Staphylococcus infection 
 Humans are natural carriers of S. aureus. Thirty to fifty percent of healthy individuals 
are colonized, with ten to twenty percent persistently colonized (Noble et al., 1967; Casewell 
and Hill, 1986). Individuals colonized with S. aureus are at increased risk for subsequent risk 
(Wenzel and Perl, 1995). S. aureus rates of colonization are high among individuals with 
type 1 diabetes (Tuazon et al., 1975), intravenous drug users (Tuazon and Sheagren, 1974), 
individuals undergoing hemodialysis (Yu et al., 1986), surgical patients (Weinstein, 1959; 
Kluytmans et al., 1995), and individuals with immunodeficiency syndrome (Weinke, 1992). 
S. aureus pathogenesis has five stages: colonization, local infection, systemic dissemination 
and/or sepsis, metastatic infection and toxinosis (Archer, 1998). Symptoms of staphylococcal 
food poisoning that appear 30 minutes – 8 hours after ingestion are abdominal cramps, 
nausea, vomiting, and sometimes diarrhea (diarrhea does not appear by itself) (Le Loir et al., 
2003) 
In addition to nosocomial (hospital-acquired) infections caused by S. aureus,  
infections by this pathogen have also been associated with many other maladies and 
syndromes such as: furuncle or carbuncle, impetigo bullosa, cellulitis, surgical wound 
infection, pyomyositis, botryomycosis, hospital-acquired bacteremia, acute or right sided 
endocarditis, hematogenous osteomyelitis, septic arthritis, epidural abscess, brain abscess, 
hospital-acquired pneumonia, empyema, septic shock, toxic shock syndrome, scalded skin 
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syndrome, foodborne gastroenteritis, and renal carbuncle (Archer, 1998). To prevent 
nosocomial S. aureus infections, several options are being explored. The Centers for Disease 
Control and Prevention established guidelines for preventing the transmission of nosocomial 
pathogens in an attempt to prevent the transmission of staphylococci within the hospital 
(Garner, 1996). In addition, the use of systemic or topical agents, to decrease nasal carriage, 
has been shown to reduce the incidence of S. aureus infections (Kauffman and Bradley, 
1997).  
Escherichia coli 
Morphology and Growth Characteristics 
Escherichia coli (E. coli) is a gram negative, facultative anaerobic, non-spore forming 
rod-shaped bacteria. E. coli has many strains and many of them are not harmful. Some are 
even beneficial to humans. E. coli normally resides among the normal microflora of the 
intestines. Harmful or pathogenic E. coli strains also are capable of residing in the intestines. 
E. coli is an indicator organism and its presence in food and water is an indication of fecal 
contamination. E. coli can be divided into six groups: 1) enteropathogenic (EPEC), 2) 
enterotoxigenc (ETEC),3) shiga toxin producing/enterohemorrhagic (STEC/EHEC), 4) 
enterinvasive (EIEC), 5) enteroaggregative (EAEC), and diffusely adherent (DAEC) (Jafari 
et al. 2012). The Escherichia coli O157:H7 used in the experiments described in the present 
thesis belong to the EHEC group which is known for causing hemorrhagic colitis or other 
serious complications in infected persons; therefore, the information in the following 
paragraphs will focus mainly on E. coli O157:H7. 
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Escherichia coli O157:H7 
Escherichia coli is a foodborne pathogen associated with foodborne disease outbreaks 
all around the world. The serotype O157:H7 is responsible for the majority of E. coli 
associated foodborne outbreaks in the United States (Karmali et al., 2010). E. coli O157:H7 
was first identified as a human pathogen in 1982, when it was implicated in two outbreaks of 
hemorrhagic colitis (Riley et al., 1983). The H7 type was initially isolated in 1944 from a 
human diarrheal sample, whereas the O157 type was first isolated and named in 1972 from 
swine diarrheal samples (Orskov et al., 1977). E. coli O157:H7 releases a shiga-like toxin 
which binds to endothelial cells expressing globotriaosylceramide-3 (Gb3) which allows 
absorption of the toxin into the bloodstream and this toxin’s distribution to other organs 
(Sandvig, 2001). E. coli strains that produce Shiga toxins are referred to as Shiga toxin-
producing E. coli (STEC) because of the toxin they produce resembles the toxin produced by 
Shigella dysenteriae type 1 (Calderwood et al., 1996). E. coli O157:H7 has an optimum 
growth temperature of 30 to 42°C, optimum growth pH of 6 to 8, and is unable to ferment 
sorbitol within 24 hours (Tsai and Ingham, 1997). 
E coli O157:H7 is closely related, genetically, to E coli O55:H7, an enteropathogenic 
strain that causes diarrhea among infants worldwide (Whittam et al., 1993). As with the 
enteropathogenic strains, E coli O157:H7 can adhere to epithelial cells and produce lesions 
(Nataro and Kaper, 1998). 
Contamination sources 
 E. coli O157:H7 is transmitted by food and water or directly from person to person 
through cross contamination. Most outbreaks have been traced to foods derived from cattle 
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such as ground beef and raw milk (Pierard, 1992; Wall et al., 1996; Griffin, 1995). In 
addition to dairy products and ground beef, products such as steak tenderized by injection, 
kabobs, ready to eat meats, salami, venison jerky, cheese, milk, butter, yogurt, ice cream, 
apple juice, grapes, coleslaw, lettuce, spinach, alfalfa sprouts, and melons, have also been 
associated as potential hosts for E. coli O157:H7 (Rangel et al., 2005).   
Escherichia coli O157:H7 outbreaks in foods 
 The first E. coli O157:H7 outbreaks in the United States occurred in Oregon and 
Michigan in 1982, when the pathogen was isolated from individuals suffering from bloody 
diarrhea and severe abdominal cramps (CDC, 1982). In 2006, a multistate outbreak occurred 
in fresh spinach. In this outbreak, E. coli O157:H7 was responsible for 199 illnesses, 102 
hospitalizations, 31 cases of hemolytic-uremic syndrome (HUS), and 3 deaths across 26 
states (CDC, 2006). The consumption of contaminated prepackage cookie dough in 2009 was 
associated with an outbreak across multiple states. There were 72 reported cases of illness, 34 
hospitalizations and 10 individuals developed hemolytic uremic syndrome (HUS) (CDC, 
2009b). In 2011, contaminated romaine lettuce led to 58 infections, 33 hospitalizations, and 3 
individuals developed hemolytic uremic syndrome, and no deaths were reported (CDC, 
2012). 
Characteristics of E. coli O157:H7 infection 
Infection due to E. coli O157:H7 typically occurs after ingestion of contaminated 
food. The minimum infectious dose of E. coli O157:H7 is 10 to 100 CFU compared to over 
one million CFU for other pathogenic E. coli strains (Greig et al., 2010). The fatality rate in 
humans is roughly 1% (Besser et al., 1999). Typically the incubation period for the onset of 
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disease symptoms is 3 to 4 days during which, E. coli O157:H7 colonizes in the intestines 
(Phillips et al., 2000). Illness usually begins with abdominal cramps and non-bloody diarrhea, 
but eventually becomes grossly bloody (Mead and Griffin, 1998; Feng, 2012). Extreme 
diarrhea appears to consist of blood and mucus and occurs every 15 to 30 minutes (Feng, 
2012). Roughly 10-15% of individuals that are infected with E. coli O157:H7 develop 
hemolytic uremic syndrome 5-13 days after the onset of diarrhea (Tarr et al., 2005; Scheiring 
et al., 2009). In some extreme cases, some patients may suffer kidney damage and kidney 
failure, seizures, coma or ultimately, death (Martin et al., 1990; Bell et al., 1994; Boyce et al., 
1995; MacDonald et al., 1998). 
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 Abstract  
The antibacterial effectiveness of phenyllactic acid (PLA) or phosvitin alone or in 
combination against Listeria monocytogenes (LM), Salmonella enterica (SE), Escherichia 
coli O157:H7 (EC), and Staphylococcus aureus (SA) in brain heart infusion (BHI) broth and 
cream of chicken soup was investigated. Separate samples of broth or soup with added 
antimicrobials alone or combined, were inoculated with those same pathogens to obtain an 
initial viable count of 5.0 Log10 CFU ml-1 (broth) and 4.0 Log10 CFU ml-1 (soup) for each 
pathogen. Broth or soup without added antimicrobials served as control. Minimum inhibitory 
concentrations (MICs) and growth curves for the pathogens in BHI (35 °C, 24 hours) were 
obtained by using a Bioscreen C turbidometer (OD600nm). Growth of the pathogens in soup 
(12 °C, 7 days) and at 35 °C for 6 hours was monitored by surface plating samples on 
appropriate selective agar. The MIC of PLA in broth was 2.5 mg ml-1 for all four pathogens. 
In control soup at 12 ºC all four pathogens grew and reached populations ranging from 5.87 
to 6.47, 7.27 to 7.72 and 7.90 to 8.50 Log CFU ml-1 at 3, 5, and 7 days, respectively.  
Phosvitin (60 mg ml-1) alone exhibited a significant growth inhibitory effect against LM 
(P<0.05).  Compared to control, populations of viable LM were 1.53, 3.13, and 2.90 Log 
CFU ml-1 lower at 3, 5, and 7 days, respectively.  In contrast, PLA at 3.75 or 5.0 mg ml-1 was 
bactericidal to all four pathogens (P<0.05).  In soup with PLA (5.0 mg ml-1) no viable LM 
and SE was detected at day 1 and day 5, respectively and no viable EC or SA was detected at 
day 7.  Phosvitin was less inhibitory to LM, SE and EC in soup held at 35 ºC compared to 12 
ºC, and failed to inhibit SA at 35 ºC.  At 35 ºC none of the pathogens could be detected at 6 
hours in soup with added PLA (5 mg ml-1) by plating or enrichment.  Only few viable cells of 
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SA were detected at 4 hours and, as early as 2 hours, none of the other three pathogens were 
detected. At 12 ºC or 35 ºC, combinations of PLA and phosvitin, while significantly 
inhibitory (P<0.05) compared to control, did not produce antibacterial effects greater than 
that exhibited by PLA alone. Based on these results PLA at 3.75 or 5.0 mg ml-1 has good 
potential for assuring the microbial safety of cream of chicken soup under temperature-abuse 
conditions. 
1.  Introduction 
The rapidly growing need of time-constrained consumers for convenience foods has 
resulted in an explosive growth in sales in ready-to-eat (RTE) foods including a variety of 
soups, sandwiches and hot snacks in supermarket delicatessens and in convenience stores. 
Increased sales of these RTE foods may result in heightened risks of microbial contamination 
as food handlers prepare larger batches to meet customer demand.  Proper hygienic practices 
of food handlers, safe hot-holding temperatures during serving and proper refrigeration 
during storage are important to ensuring the microbial safety of these RTE foods.  More 
often, proper temperature control is the principal or only factor that foodservice operations 
can rely on to control foodborne pathogens in many potentially hazardous RTE foods.  
Therefore, temperature abuse of these foods can result in foodborne illness. Based on the 
FDA Food Code, potentially hazardous foods should be maintained at a temperature of 60 ºC 
or above or at 5 ºC or less (FDA Food Code, 2001) for service to consumers.  
A promising approach to provide added protection of RTE foods (beyond safe hot-
holding or refrigerated storage temperature) against foodborne pathogens is the use of 
antimicrobial ingredients.  Antimicrobial ingredients may be classified as synthetic or 
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naturally occurring compounds.  Although the toxicological safety of commonly used, 
approved synthetic antimicrobials is assured by regulatory authorities, health conscious 
consumers are increasingly opposed to the addition of synthetic chemicals to foods (Ray, 
1992). In addition, those consumers are highly concerned with the long-term adverse effects 
to their health that might occur from eating foods containing synthetic preservatives.  Due to 
increased consumer concern over consumption of food that has been formulated with 
synthetic chemical preservatives, the demand for more natural and minimally processed food 
has increased (Cleveland et al., 2001). Therefore, identification of novel effective ways of 
ensuring the microbial safety of RTE foods is vitally important to the food industry. In this 
regard, the use of naturally occurring antimicrobials to control foodborne human enteric 
pathogens may provide a solution to this problem.  Natural antimicrobials can be obtained 
from animal, plant or microbial sources. 
 Phosvitin is a naturally occurring antimicrobial protein found in the yolk of hens’ 
eggs. It is a phosphoprotein that represents 7% of the yolk proteins (Mecham and Olcott, 
1949). The amino acid composition of phosvitin is 50% serine of which 90% are 
phosphorylated (Clark, 1985). This unique composition of phosphorylated serines makes 
phosvitin a very strong metal chelator of various multivalent metals such as iron, calcium, 
and magnesium (Grizzuti and Perlmann, 1975; Vieira, 2007; Sattar Khan et al., 2000). 
Phosvitin is believed to have antimicrobial properties associated with the chelation of 
cations, such as iron (Sattar Khan et al., 2000). Currently, the antimicrobial efficacy of 
phosvitin has been published in a paper by Sattar Khan et al (2000). In that study, phosvitin 
(0.1 mg ml-1) in combination with heat stress (50 °C for 20 min) significantly inactivated 
Escherichia coli (Sattar Khan et al., 2000). 
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 Phenyllactic acid (PLA) is an antimicrobial compound isolated from Geotrichum 
candidum as well as, more commonly, Lactobacillus plantarum (Dieuleveux and Gueguen, 
1998; Lavermicocca et al., 2000; Lavermicocca et al., 2003). It is a naturally occurring acid 
that has four main forms, D-3-phenyllactic acid, L-3-phenyllactic acid, DL-3-phenyllactic 
acid, and 4-hydroxyphenyllactic acid all of which are produced by either Geotrichum 
candidum or Lactobacillus plantarum 21B.  Published reports on the antibacterial effects of 
all four forms against foodborne pathogens are scarce.  The inhibitory effects of DL-3-
phenyllactic acid and D-3-phenyllactic acid against some fungal species isolated from flour, 
cereals and bakery products have been reported (Lavermicocca et al., 2000; Lavermicocca et 
al., 2003).  Also, D-3-phenyllactic acid has been shown to inhibit growth of Listeria 
monocytogenes in milk, and DL-3-phenyllactic acid has been shown to inhibit 
Staphylococcus aureus and Escherichia coli O157:H7 in vitro (Ohhira et al. 2004; 
Dieuleveux et al. 1998).  
To our knowledge there is no published research on the antibacterial efficacy of 
phosvitin against L. monocytogenes, S. enterica, E. coli O157:H7, and S. aureus or the 
combined use of DL-3-phenyllactic and phosvitin against those same pathogens. 
Accordingly, the objectives of the present study were: 1) to establish the minimum inhibitory 
concentration of PLA for four foodborne human enteric pathogens in brain heart infusion 
broth and 2) to evaluate the antimicrobial efficacy of phosvitin or PLA individually or in 
combination against the foodborne pathogens in cream of chicken soup stored at abusive 
temperatures (12 °C and 35 °C). 
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2.  Material and methods 
2.1. Bacterial cultures and culture conditions 
Five strains of Listeria monocytogenes (Scott A NADC 2045,serotype 4b, H7969 
serotype 4b , H7962 serotype 4b, H7596 serotype 4b, and H7762 serotype 4b), five serotypes 
of Salmonella enterica (Enteritidis-ATCC13076, Heidelberg, Typhimurium-ATCC 14802, 
Gaminara-8324, and Oranienburg-9329), five strains of Escherichia coli O157:H7 
(FRIK125, ATCC 35150, ATCC 43894, ATCC 43895, and 93-062), and three strains of 
Staphylococcus aureus (ATCC 6538, ATCC 25923, and BAA-44) were obtained from the 
culture collection of the Microbial Food Safety Laboratory, Iowa State University, Ames, IA. 
Stock cultures were kept frozen (-70 ºC) in brain heart infusion (BHI) broth (Difco,; Becton 
Dickinson, Sparks, Md) supplemented with 10% (vol/vol) glycerol. Sealed vials of frozen 
stock cultures, thawed under cold running water, were activated in tryptic soy broth (TSB; 
Difco, Becton Dickinson) at pH 7.2 and incubated at 35 °C. At least two consecutive 18 to 
24-h transfers of each stock culture were carried out before using the cells as inocula in each 
experiment. 
2.2.  Preparation of inoculum 
Equal volumes (6 ml per culture) of each of the working cultures of Listeria 
monocytogenes, Salmonella enterica, Escherichia coli O157:H7 and Staphylococcus aureus 
were combined in a sterile centrifuge tube. The cells were harvested by centrifugation 
(10,000 x g, 10 min, 4 °C) using a Sorvall Super T21 centrifuge (American Laboratory 
Trading, Inc., East Lyme, CT) and washed once in 0.85% (wt/vol) saline. The pelleted cells 
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were suspended in fresh 0.85% (wt/vol) saline to obtain a final viable cell concentration of 
approximately109 CFU ml-1. Viable colony counts of the washed cell suspensions were 
evaluated by serially diluting (10-fold) and surface plating samples on tryptic soy agar 
(Difco, Becton Dickinson) supplemented with 0.6% yeast extract (TSAYE). The cell 
suspensions were used to inoculate BHI broth or commercially sterile cream of chicken soup. 
2.3.  Antimicrobials 
Phosvitin was supplied by Dr. Dong Ahn from the Animal Science Department at 
Iowa State University, Ames, IA. A commercial preparation of DL-3-Phenyllactic acid 
(PLA) was purchased from Sigma-Aldrich (St. Louis, Missouri) 
2.4.  Preparation of treatment solutions for Bioscreen C assay 
BHI broth with added PLA  (0, 0.312, 0.625, 1.25, or 2.5 mg ml-1) was filter sterilized 
using 0.22 µm pore size filters (Fisher Scientific) and the pH was adjusted to 6.0 using 1M 
sodium hydroxide or 1M hydrochloric acid. Samples (2.5-ml) of BHI broth with added 
antimicrobials and the control (BHI broth with no added antimicrobial) in test tubes were 
each inoculated with 25 µl of diluted (1:100) Listeria monocytogenes, Salmonella enterica, 
Escherichia coli O157:H7 or Staphylococcus aureus cell suspensions to obtain a final cell 
concentration of approximately 105 CFU ml-1 of sample. 
2.5  Bioscreen C assay 
Inoculated samples (aliquots of 200 µl) were added in triplicate to the wells of a 100-
well microtiter plate for the Bioscreen C Turbidometer (Growth Curves USA Piscataway, 
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NJ), an automated microbial growth analyzer and incubator. Plates were incubated in the 
Bioscreen C at 35 °C for 24 h and the machine took optical density (OD) measurements at 
600 nm every 30 min, with shaking of samples for 10 seconds prior to each OD reading. 
Minimum inhibitory concentration (MIC) was defined as the lowest treatment concentration 
that completely inhibited (< 0.05 OD unit increase) microbial growth for 24 hr in BHI broth 
at 35 ºC. 
2.6.  Preparation and inoculation of soup 
Campbell’s Cream of Chicken Soup in cans was purchased from a local grocery store. 
The soup was reconstituted with sterile distilled water and prepared according to the 
directions stated on the package. Soup ingredients are shown in Table 1. After the soup was 
boiled, 6-ml aliquots of the soup were aseptically transferred into sterile 15 ml screw cap 
tubes. Separate sets of the soup in tubes were tempered to ~ 35 °C and ~ 12 °C. Phosvitin, 
phenyllactic acid or their combinations was added to each tube to give the following 
concentrations: PLA (3.75 mg ml-1), PLA (5 mg ml-1), phosvitin (60 mg ml-1), PLA (3.75 mg 
ml-1) + phosvitin (60 mg ml-1) and PLA (5 mg ml-1) + phosvitin (60 mg ml-1). Both 
phenyllactic acid and phosvitin were added to the tubes after the addition of tempered soup.  
Soup without added antimicrobial served as a control. Tubes of soup with added 
antimicrobials were mixed via vortexing and then inoculated with 50 µl of the suspension of 
washed cells of the foodborne pathogens to give a final cell concentration 
ofapproximately104 CFU ml-1 for each pathogen. After inoculation, each tube of soup was 
mixed by vortexing and stored at either 12 °C or 35 °C in thermostatically controlled 
incubators. 
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2.7.  Microbiological analysis 
Inoculated tubes of soup stored at 12 °C were tested for numbers of viable pathogens 
every 2 days starting at day 1 for a total of 7 days whereas, tubes of soup held at 35 °C were 
tested at 1, 2, 3, 4, and 6 h. Ten-fold serial dilutions of the soup were prepared using sterile 
buffered peptone water. Aliquots (1.0 ml or 0.1ml) of the soup or diluted samples of soup 
were surface plated (in duplicate) on Modified Oxford agar (for Listeria monocytogenes), 
XLT-4 (for Salmonella enterica), Sorbitol MacConkey agar (for Escherichia coli O157:H7), 
and Baird Parker agar (for Staphylococcus aureus).  Inoculated plates were incubated at 35 
°C and bacterial colonies were counted at 48h.  All previously mentioned selective agar 
media were purchased from Difco, Becton Dickinson, Sparks, Md. 
2.8.  Measurement of pH and water activity 
Prior to inoculation, the initial pH and water activity of each soup sample including 
controls were measured at day 0. Measurements of pH were taken using an Orion Model 525 
pH meter (Orion Research, Inc., Boston, Massachusetts) fitted with a glass electrode. Water 
activity measurements were taken using the Aqualab CX2 water activity meter (Decagon 
Services, Pullman, Washington). 
2.9.  Statistical analysis 
Three replications of each experiment were performed. Mean numbers of viable 
Listeria monocytogenes, Salmonella enterica, Escherichia coli, and Staphylococcus aureus 
survivors were statistically analyzed using SAS statistical software version 9.3 (SAS Institute 
Inc., Cary, N.C.). Treatment means were evaluated for statistically significant differences 
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using the Waller-Duncan test. Significant differences were defined at P < 0.05 for all the 
experimental data. 
3.  Results 
3.1  Growth inhibition by phenyllactic acid in BHI broth 
 The effect of PLA (0, 0.312, 0.625, 1.25 and 2.50 mg ml-1) on the growth of L. 
monocytogenes, S. enterica, E. coli O157:H7, and S. aureus in brain heart infusion (BHI) 
broth at pH 6.0 is shown in figures 1-4. L. monocytogenes, S. enterica, and E. coli O157:H7 
grew in control BHI broth and at about10 h reached optical density (OD600nm) values of 
0.52, 0.44, and 0.56, respectively.  S. aureus in control broth reached a maximum OD600nm of 
0.44 at approximately 16 h.  Compared to control, the lowest PLA concentration tested 
(0.312 mg ml-1) inhibited growth of the Gram-positive pathogens - L. monocytogenes and S. 
aureus (Figs. 1 and 4) but not S. enterica or E. coli O157:H7 (Figs. 2 and 3).  Growth 
inhibition of all four pathogens increased with increase in concentration of PLA from 0.625 
to 2.50 mg ml-1 with the highest PLA concentration (2.5 mg ml-1) completely inhibiting 
growth; absolutely no increase in OD was observed for 24 h at that high PLA concentration 
(Figs. 1-4). The minimum inhibitory concentration (MIC) of PLA for all four pathogens in 
BHI broth (35 ºC) was 2.5 mg ml-1. 
3.2.  The pH and water activity of cream of chicken soup  
 The initial pH of the cream of chicken soup was 5.85 and the initial water activity 
was 0.988.  The pH values for samples of soup that contained phosvitin (60 mg ml-1), PLA 
(3.75 mg ml-1) and PLA (5.0 mg ml-1) were 5.33, 3.66 and 3.34, respectively. Soup that 
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contained combinations of the antimicrobials had pH values of 4.83 (PLA at 3.75 mg ml-1 + 
phosvitin) and 4.57 (PLA at 5.0 mg ml-1 + phosvitin).  The water activity values for soup 
samples with or without antimicrobials ranged from 0.986 to 0.988.   
3.3  Growth inhibition by phenyllactic acid and phosvitin in cream of chicken soup at 12 ºC 
 Viable counts of all four pathogens in cream of chicken soup (12°C) are shown in 
Tables 2-5. The initial viable count for each of the four pathogens was 4.0 Log10 CFU ml-1.  
L. monocytogenes grew in control soup and reached 8.5 Log10 CFU ml-1 at day 7 (Table 2).  
Phosvitin alone inhibited growth of the pathogen throughout storage; viable counts in soup 
with added phosvitin were 1.53, 2.13, and 2.90 Log cycles lower than those of control at 3, 5, 
and 7 days, respectively.  Initial populations of L. monocytogenes in soup with added PLA 
(3.75 or 5.0 mg ml-1) declined throughout storage at 12 C.  PLA at 3.75 mg ml-1 reduced 
initial numbers of L. monocytogenes by 0.37, 1.47, 2.95 and 3.43 Log cycles at 1, 3, 5, and 7 
days, respectively.  PLA (5 mgml-1 ) inactivated initial numbers of the pathogen by 2.04 and 
3.23 Log cycles at 1 and 3 days, respectively; however, no viable L. monocytogenes was 
detected by plating or enrichment at 5 or 7 days of storage (Table 2).  Combinations of PLA 
and phosvitin significantly inhibited growth of L. monocytogenes compared to control 
(P<0.05); however, those combinations were less effective in inhibiting growth of the 
pathogen compared to PLA (3.75 or 5.0 mg ml-1) used alone (Table 2). 
Viable populations of S. enterica in control soup reached 8.0 Log10 CFUml-1 at day 7 
(Table 3).  Throughout storage there were no significant differences in viable counts of S. 
enterica in soup with added phosvitin compared with those of control (P>0.05).  The higher 
concentration of PLA (5.0 mg ml-1) was the most effective of all treatments tested; at day 1 
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and throughout the remainder of storage, no viable salmonellae were detected by plating or 
enrichment. PLA (5.0 mg ml-1) and phosvitin combined significantly (P<0.05) inhibited 
growth of S. enterica compared to control but was less effective in inhibiting growth of the 
pathogen compared to PLA (3.75 or 5.0 mg ml-1 ) used alone (Table 3). 
In the control soup the viable count of Escherichia coli O157:H7 increased during 
storage and at 7 days numbers of the pathogen were 8.30 Log10 CFU ml-1 (Table 4).  As 
observed with S. enterica, there were no significant differences in viable counts of E. coli 
O157:H7 in soup with added phosvitin compared with those of control (P>0.05).  Both 
concentrations of PLA in the soup were bactericidal to E. coli O157:H7; PLA at 3.75 and 5.0 
mg ml-1 reduced initial numbers of the pathogen by 0.3 and 1.07 Log respectively, at day 1.  
In soup with added PLA (5 mg ml-1), reductions in viable counts were 2.57, 3.80, and 4.00 
Log CFU ml-1 at 3, 5, and 7 days, respectively.  No viable E. coli O157:H7 was detected by 
plating or enrichment at 7 days of storage.  Both PLA and phosvitin combinations 
significantly inhibited E. coli O157:H7 growth compared to control (P<0.05).  Those two 
combination treatments were not significantly different from each other with respect 
inhibiting growth of E. coli O157:H7 (P>0.05) and were less effective in inhibiting growth of 
the pathogen compared to PLA at 3.75 or 5.0 mg ml-1 (Table 4). 
The initial population of S. aureus in control soup increased steadily and attained a 
level of 7.90 Log10 CFU ml-1 at 7 days of storage (Table 5).  Compared to control, phosvitin 
exhibited a significant growth inhibitory effect against S. aureus at 3 and 5 days (P<0.05); 
Log differences in viable count between control soup and soup with added phosvitin were 
1.07 (day 3) and 0.93 (day 5).   PLA at 3.75 mg ml-1 reduced initial counts of the pathogen by 
1.23 and 1.47 Log cycles at day 1 and day 3, respectively.  No viable S. aureus was detected 
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by plating or enrichment at 5 and 7 days (Table 5).  At 1, 3, and 5 days, PLA at 5 mg ml-1  
reduced counts of the pathogen by 2.57, 2.97, and 3.77 Log cycles, respectively; no viable S. 
aureus was detected at day 7 (Table 5).  As previously mentioned for L. monocytogenes, S. 
enterica and E. coli O157:H7, combinations of PLA and phosvitin in soup significantly 
inhibited growth of S. aureus compared to control or phosvitin (P<0.05); however, those 
combinations were relatively less inhibitory to the pathogen compared to PLA at 3.75 or 5.0 
mg ml-1 (Table 5). 
3.3  Growth inhibition by phenyllactic acid and phosvitin in cream of chicken soup at 35 ºC 
Viable counts of all four pathogens in the cream of chicken soup (35°C) are shown in 
Tables 6-9. The average initial viable counts of the pathogens ranged from 3.73 to 4.5 Log10 
CFU ml-1.  The initial viable count of L. monocytogenes in control soup increased to 6.03 
Log10 CFU ml-1 in 6 hours (Table 6).  For up to 4 hours there were no significant differences 
in viable counts of the pathogen in soup with added phosvitin alone compared to control soup 
(P>0.05).  At 6 hours the viable counts of L. monocytogenes in soup with phosvitin were 5.07 
Log10 CFU ml-1, a difference of 0.96 Log cycles lower than control (P<0.05).  In 1 hour, PLA 
at 3.75 and 5.0 mg ml-1 reduced initial counts of the pathogen by 2.90 and 3.83 Log cycles, 
respectively (P<0.05).  No viable L. monocytogenes in soup with added PLA was detected by 
plating or enrichment as early as 2 hours (5.0 mg PLA ml-1) or 3 hours (3.75 mg ml-1). At 3, 
4, and 6 hours, viable counts of the pathogen in soup with PLA (3.75 mg ml-1 ) and phosvitin 
combined were significantly lower (0.80, 1.37 and 2.23 Log cycles, respectively) than counts 
in control soup (P<0.05).  Soup with the higher PLA concentration (5.0 mg ml-1 ) combined 
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with phosvitin had numbers of viable L. monocytogenes that were significantly lower than 
those of soup with PLA (3.75) combined with phosvitin (P<0.05). 
The initial viable count of S. enterica in control soup at 35 ºC reached 7.10 Log10 
CFU ml-1 in 6 hours (Table 7).  Phosvitin alone in soup at that temperature did not 
significantly affect growth of S. enterica compared to control (P>0.05).  PLA at 3.75 mg ml-1 
reduced initial counts of S. enterica by 2.70, 2.93 and 3.03 Log cycles at 2, 3, and 4 hours, 
respectively (P<0.05); no viable S. enteric was detected by plating or enrichment at 6 hours.  
In contrast, PLA at 5.0 mg ml-1 reduced the initial viable count of S. enterica by 3.53 Log 
cycles in 1 hour and completely inactivated the pathogen within 2 hours; no viable counts 
were detected in the soup by plating or enrichment at 2 to 6 hours.  Combinations of PLA 
and phosvitin in soup significantly inhibited growth of S. enterica compared to control 
(P<0.05). No significant differences in viable counts of the pathogen was observed between 
the two PLA/phosvitin combinations at 1 to 4 hours (P>0.05).  At 6 hours viable counts 
(Log10 CFU ml-1) of S. enterica in soup with PLA and phosvitin combined were 4.00 (3.75 
mg PLA + phosvitin) and 1.70 (5.0 mg PLA + phosvitin). 
The initial viable count of E. coli O157:H7 in soup at 35 ºC increased to 7.90 Log10 
CFU ml-1 within 6 hours (Table 8).   At 1 to 4 hours, there no significant differences in E. 
coli O157:H7 survivors in control soup compared to soup with added phosvitin alone 
(P>0.05); however, at 6 hours viable counts of the pathogen increased to 7.90 Log10 CFU ml-
1
 compared to 6.50 Log10 CFU ml-1 in soup with added phosvitin alone (P<0.05).  At 1 and 2 
hours, PLA at 3.75 mg ml-1 reduced initial numbers of the pathogen in soup by 1.0 and 2.87 
Log cycles, respectively; no viable cells of the pathogen were detected at 3 to 6 hours (Table 
8).  In soup with added PLA (5 mg ml-1), the initial counts of the pathogen was reduced by 
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2.68 Log10 CFU ml-1 in 1 hour and no viable cells could be recovered from the soup at 2 
through 6 hours.  Compared to control, soup with PLA/phosvitin combinations significantly 
inhibited growth of E. coli O157:H7 (P<0.05) with a greater decline in cell viability 
occurring in soup that contained 5.0 mg PLA ml-1. At 3, 4, and 6 hours, viable counts of the 
pathogen in soup with the higher concentration of PLA (5.0 mg ml-1) combined with 
phosvitin were lower than those of soup with PLA (3.75 mg ml-1) plus phosvitin (P<0.05).   
From 2 to 6 hours viable counts E. coli O157:H7 in soup with PLA/phosvitin combinations, 
irrespective of the PLA concentration, were lower than those in soup with added phosvitin 
alone (P<0.05). 
At 35 ºC the S. aureus in control soup attained a maximum concentration of 5.90 
Log10 CFU ml-1 at 4 hours (Table 9).  Contrary to our observations of soup held at 12 ºC, 
phosvitin in soup at 35 ºC did not significantly inhibit growth of S. aureus compared to 
control (P>0.05).  The S. aureus exhibited a heightened sensitivity to PLA in the soup at 35 
ºC with about 3.84 to 4.0 Log reduction in initial viable counts occurring as early as  1 hour.   
At 2 to 6 hours Log reductions of S. aureus in soup with PLA at 3.75 mg ml-1 and 5.0 mg ml-
1
 ranged from 3.75 to 4.00 and 2.74 to 4.00, respectively.  Compared to control  and soup 
with phosvitin alone, soup with PLA and phosvitin added as combined treatments had 
significantly lower viable counts of the pathogen (P<0.05); however, those same 
combinations  were not as lethal to the pathogen compared to PLA at 3.75 or 5.0 mg ml-1 
(Table 9). 
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4.  Discussion 
Based on the results on growth of the four pathogens in BHI broth with added PLA, 
the  observed growth inhibition of both Gram negative and Gram positive pathogens by PLA 
suggests that PLA might have a broad spectrum of inhibitory activity for various types of 
foodborne bacteria. Our observation agreed with those of a previous study in which the agar-
well diffusion assay was used to evaluate the antibacterial effect of PLA (Dieuleveux et al., 
1998). Those same researchers reported that PLA (20 mg ml-1) inhibited growth of several 
Gram negative and Gram positive bacteria isolated from human sources (Dieuleveux et al., 
1998). 
Generally, it is well recognized that antimicrobial concentrations that are effective 
microbial inhibitors in in laboratory media may not be the same in actual food systems 
because the food matrix is complex and different in composition when compared to 
microbiological media.  Since the published report on the antibacterial effects of phosvitin 
describe results obtained from E. coli in microbiological media (Sattar Khan et al., 2000) and 
only one study reported the effects of PLA against L. monocytogenes in milk and cheese 
(Dieuleveux and Gueguen, 1998), more studies on the antibacterial effects of PLA and 
phosvitin against human enteric pathogens in foods are warranted.    
In the present study concentrations (3.75 mg ml-1 or 5 mg ml-1) of PLA were 
evaluated alone or combined with phosvitin (60 mg ml-1) to control pathogens in cream of 
chicken soup at abusive temperatures. The selection of phosvitin (60mg ml-1) for use in the 
present study was based on our preliminary studies which demonstrated that phosvitin at 60 
mg ml-1strongly inhibited the growth of the four pathogens in BHI broth at 35 °C (data not 
shown).  Data from the present study suggest that phosvitin alone is more inhibitory to the 
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growth of the four pathogens in cream of mushroom soup at 12 ºC compared to 35 ºC.  The 
temperature of 35 ºC was used to represent temperature abuse of the soup; however, that 
temperature is optimum for growth of the pathogens used in the present study.  It seems that 
it is more difficult for some antimicrobial agents to inhibit growth of pathogens at the 
pathogens’ optimum growth temperature.  It is well known that bacteria are adapted to 
function optimally in their normal physiological environments.  In this regard, any 
environmental change from their optimum environmental conditions imposes a stress on 
bacteria.  The extent of the environmental change such as a reduction in growth temperature 
to 12 ºC, can influence whether the bacteria exhibit an increased lag phase, grow slower, stop 
growing or become inactivated (Ray, 1986; Russell et al., 1995).   Therefore, it is likely that 
the observed difference in antibacterial activity of phosvitin was due to stress imposed by 
both phosvitin and the sub-optimum growth temperature (12 °C) used in the present study. 
In cream of chicken soup at 35 °C, PLA at 3.75 or 5.0 mg ml-1 exerted a bactericidal 
effect on all four pathogens.  We observed that PLA exhibited a greater antimicrobial effect 
against the Gram-positive pathogens (L. monocytogenes and S. aureus) compared to the 
Gram negative pathogens (E. coli O157:H7 and S. enterica).  In fact, within 2 hours, the 
lower concentration of PLA (3.75 mg ml-1) in soup at 35 °C reduced initial populations of L. 
monocytogenes and S. aureus by 3.52 and 3.80 Log cycles respectively whereas, under those 
same conditions, initial polulations of S. enterica and E. coli O157:H7 were reduced to a 
lesser extent (2.70 and 2.87 Log cycles, respectively) (Tables 6-8).  Our observations are in 
agreement with the results of a previous study which revealed that Gram positive bacteria 
isolated from humans were more sensitive to PLA than the Gram negative isolates at 37 °C 
based on a zone inhibition tests using the agar-well diffusion assay (Dieuleveux et al., 1998).  
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This reasons for this observed difference remains speculative and warrants further 
investigation. 
Contrary to our expectation, combinations of PLA and phosvitin added to cream of 
chicken soup were not more inhibitory that PLA alone.  For all four pathogens the 
antibacterial effect of PLA in the soup was reduced when that antimicrobial was used in 
combination with phosvitin.  Generally, the efficacy of many natural antimicrobials for 
inhibiting growth of microorganisms may be reduced by certain components of foods (Glass 
and Johnson, 1994).  Increased concentrations of proteins or fats have been supposedly 
linked to the protection of microorganisms from inactivation by natural antimicrobials 
(Aureli et al., 1992; Pandit and Shelef, 1994; Tassou et al., 1995).  Phosvitin is a glycoprotein 
and it is likely that its addition to the soup protected the pathogens against the killing effect 
of PLA because of an increase in protein content in the soup.  Also, lipophilic organic acids 
such as lactic, sorbic and acetic acid exhibit greater antimicrobial effect at low pH values 
which favor more of the undissociated form of those acids (Davidson, 2001). Preliminary 
studies in our laboratory revealed increased antibacterial activity of PLA with decreases in 
phosvitin concentration and vice versa (data not shown).  Also, the higher pH of soup with 
the PLA/phosvitin combination compared to that of soup of soup with PLA alone might have 
contributed to the decreased antibacterial effect of PLA because PLA has been reported to 
exert stronger antimicrobial effects at acidic pH (Ohhira et al., 2004). 
A major objective of the present study was to evaluate the antimicrobial efficacy of 
phosvitin or phenyllactic acid alone or in combination against foodborne pathogens in cream 
of chicken at 12 °C and 35 °C.  Cream of chicken soup was selected for use in the present 
study because chicken soup is a very popular soup consumed in homes, soup kitchens, salad 
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bars, and cafeterias.  Also, cream of chicken soup, unlike bullion-type soup, is a more 
complex food product that contains ingredients such as dehydrated cooked chicken, chicken 
stock, chicken fat, milk cream and food starch (Table 1) that make it challenging for 
antimicrobial agents to destroy contaminating microorganisms. The soup was intentionally 
held at 12 °C and 35 °C to simulate temperature abuse conditions that can compromise the 
microbial safety of potentially hazardous foods. The temperatures of 12 °C and 35 °C both 
reside in the temperature danger zone (5 ºC to 60 ºC) in which pathogenic bacteria can 
multiply rapidly and reach large populations thus increasing the risk of foodborne disease.  
At both temperatures PLA by itself was more effective at controlling all pathogens as 
opposed to a combination of PLA and phosvitin. Based on these findings PLA has good 
potential for enhancing the microbial safety of cream of chicken soup and reducing the risk 
of foodborne infection or intoxication in soup that might be inadvertently exposed to abusive 
temperatures that are suitable for the growth of foodborne pathogens.  Further research is 
needed to determine the influence of PLA on the sensory characteristics and quality of food. 
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TABLE 1. aIngredients in cream of chicken soup 
Chicken stock 
Water 
Vegetable Oil 
Modified Food Starch 
Wheat Flour 
Cream (Milk) 
Salt 
Dehydrated Cooked Chicken 
Soy Protein Concentrate 
Monosodium Glutamate 
Chicken Fat 
Yeast Extract 
Flavoring 
Beta Carotene for Color 
Chicken Flavor 
Partially Hydrogenated Soybean 
Partially Cottonseed Oil 
Butter (Milk) 
*Sodium 750 mg - 31% 
a
 Ingredients are listed in the same order as they appear on the label of the package 
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TABLE 2. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1 and 5 mg ml-1) 
alone or combined with phosvitin (60 mg ml-1) against Listeria monocytogenes in cream of 
chicken soup held at 12 ºC for 7 days. 
Viable count (Log10 CFU ml-1)x 
Treatment (mg ml-1) 1d 3d 5d 7d 
Control 4.10 + 0.56a 6.20 + 0.62a 7.53 + 0.21a 8.50 + 0.46a 
     
Phenyllactic acid (3.75) 3.63 + 0.06a 2.53 + 0.42c 1.05 + 1.16d 0.57 + 0.98d 
     
Phenyllactic acid (5) 1.96 + 1.03b 0.77 + 1.33d 0.00 + 0.00e 0.00 + 0.00d 
     
Phosvitin (60) 4.40 + 0.20a 4.67 + 0.32b 5.40 + 0.44b 5.60 + 0.44b 
     
PLA + Phos (3.75 + 60) 3.50 + 0.69a 4.10 + 0.10b 4.33 + 0.25c 4.47 + 0.06c 
     
PLA + Phos (5 + 60) 3.47 + 0.46a 4.27 + 0.31b 4.27 + 0.25c 4.33 + 0.31c 
xEach reported value for viable count represents the mean (standard deviation) of three 
replications of the experiment 
a,b,c,dMeans with a different letter within a column differ significantly (P<0.05) 
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TABLE 3. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1and 5 mg ml-1) alone 
or combined with phosvitin (60 mg ml-1) against Salmonella enterica in cream of chicken 
soup held at 12 ºC for 7 days. 
Viable count (Log10 CFU ml-1)x 
Treatment (mg ml-1) 1d 3d 5d 7d 
Control 4.37 + 0.29a 5.87 + 0.61a 7.27 + 0.66a 8.00 + 0.44a 
     
Phenyllactic acid (3.75) 2.17 + 1.07c 0.70 + 1.21c 0.00 + 0.00c 0.00 + 0.00d 
     
Phenyllactic acid (5) 0.00 + 0.00d 0.00 + 0.00c 0.00 + 0.00c 0.00 + 0.00d 
     
Phosvitin (60) 4.17 + 0.15ab 5.40 + 0.52a 6.63 + 0.55a 7.50 + 0.56a 
     
PLA + Phos (3.75 + 60) 3.33 + 0.15b 4.87 + 0.72ab 4.70 + 0.60b 4.23 + 0.23b 
     
PLA + Phos (5 + 60) 3.27 + 0.55b 4.07 + 0.15b 4.07 + 0.11b 3.63 + 0.06c 
xEach reported value for viable count represents the mean (standard deviation) of three 
replications of the experiment 
a,b,c,dMeans with a different letter within a column differ significantly (P<0.05) 
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TABLE 4. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1 and 5 mg ml-1) 
alone or combined with phosvitin (60 mg ml-1) against Escherichia coli O157:H7 in cream of 
chicken soup held at 12 ºC for 7 days. 
Viable count (Log10 CFU ml-1)x 
Treatment (mg ml-1) 1d 3d 5d 7d 
Control 4.47 + 0.32ab 6.03 + 0.68a 7.53 + 0.70a 8.30 + 0.30a 
     
Phenyllactic acid (3.75) 3.70 + 0.35bcd 2.53 + 0.40c 1.03 + 0.31c 0.10 + 0.17c 
     
Phenyllactic acid (5) 2.93 + 0.50d 1.43 + 1.24c 0.20 + 0.35d 0.00 + 0.00c 
     
Phosvitin (60) 4.57 + 0.06a 5.60 + 0.61a 6.93 + 0.38a 7.93 + 0.29a 
     
PLA + Phos (3.75 + 60) 3.40 + 0.78cd 4.37 + 0.15b 4.37 + 0.06b 4.00 + 0.50b 
     
PLA + Phos (5 + 60) 3.80 + 0.40abc 4.20 + 0.10b 4.07 + 0.23b 3.93 + 0.25b 
xEach reported value for viable count represents the mean (standard deviation) of three 
replications of the experiment 
a,b,c,dMeans with a different letter within a column differ significantly (P<0.05) 
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TABLE 5. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1 and 5 mg ml-1) 
alone or combined with phosvitin (60 mg ml-1) against Staphylococcus aureus in cream of 
chicken soup held at 12 ºC for 7 days. 
Viable count (Log10  CFU ml-1)x 
Treatment (mg ml-1) 1d 3d 5d 7d 
Control 4.70 + 0.10a 6.47 + 0.42a 7.70 + 0.10ay 7.90 + 0.10a 
     
Phenyllactic acid (3.75) 2.77 + 0.15b 2.53 + 0.31d 0.00 + 0.00d 0.00 + 0.00c 
     
Phenyllactic acid (5) 1.43 + 1.25c 1.03 + 0.48e 0.23 + 0.40d 0.00 + 0.00c 
     
Phosvitin (60) 4.60 + 0.00a 5.10 + 0.79b 6.77 + 0.68b 7.57 + 0.25a 
     
PLA + Phos (3.75 + 60) 3.50 + 0.10b 4.17 + 0.06c 4.37 + 0.15c 3.87 + 0.15b 
     
PLA + Phos (5 + 60) 3.47 + 0.15b 4.67 + 0.42bc 4.00 + 0.00c 3.63 + 0.57b 
xEach reported value for viable count represents the mean (standard deviation) of three 
replications of the experiment 
a,b,cMeans with a different letter within a column differ significantly (P<0.05) 
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TABLE 6. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1and 5 mg ml-1) alone 
or combined with phosvitin (60 mg ml-1) against Listeria monocytogenes in cream of chicken 
soup held at 35 ºC for 6 hours. 
Viable count (Log10 CFU ml-1)x 
Treatment (mg 
ml-1) Hour 1 Hour 2 Hour 3 Hour 4 Hour 6 
Control 4.50 + 0.17a 4.50 + 0.26a 4.83 + 0.51a 5.37 + 0.38a 6.03 + 0.32a 
      
Phenyllactic acid 
(3.75) 1.10 + 1.91b 0.48 + 0.44c 0.00 + 0.00c 0.00 + 0.00d 0.00 + 0.00d 
      
Phenyllactic acid  
(5) 0.17 + 0.29b 0.00 + 0.00c 0.00 + 0.00c 0.00 + 0.00d 0.00 + 0.00d 
      
Phosvitin (60) 3.93 + 0.74a 4.43 + 0.25a 4.33 + 0.51a 4.63 + 0.45ab 5.07 + 0.55b 
      
PLA + Phos  
(3.75 + 60) 4.10 + 0.10a 3.97 + 0.12a 4.03 + 0.32a 4.00 + 0.52b 3.80 + 0.35c 
      
PLA + Phos  
(5 + 60) 3.40 + 1.22a 3.23 + 0.74b 1.47 + 1.37b 0.93 + 0.86c 0.30 + 0.52d 
xEach reported value for viable count represents the mean (standard deviation) of three 
replications of the experiment 
a,b,c,dMeans with a different letter within a column differ significantly (P<0.05) 
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TABLE 7. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1 and 5 mg ml-1) 
alone or combined with phosvitin (60 mg ml-1) against Salmonella enterica in cream of 
chicken soup held at 35 ºC for 6 hours. 
Viable count (Log10 CFU ml-1)x 
Treatment (mg 
ml-1) Hour 1 Hour 2 Hour 3 Hour 4 Hour 6 
Control 4.53 + 0.15a 4.70 + 0.17a 5.50 + 0.20a 5.97 + 0.32a 7.10 + 0.40a 
      
Phenyllactic 
acid (3.75) 3.23 + 0.85b 1.30 + 2.25b 1.07 + 1.85d 0.97 + 1.67d 0.00 + 0.00d 
      
Phenyllactic 
acid (5) 0.47 + 0.81c 0.00 + 0.00b 0.00 + 0.00d 0.00 + 0.00d 0.00 + 0.00d 
      
Phosvitin (60) 4.50 + 0.36a 4.83 + 0.20a 5.10 + 0.36ab 5.53 + 0.06ab 5.93 + 0.67a 
      
PLA + Phos  
(3.75 + 60) 4.30 + 0.10a 4.10 + 0.00a 4.03 + 0.15bc 4.30 + 0.10bc 4.00 + 0.00b 
      
PLA + Phos  
(5 + 60) 3.80 + 0.26ab 3.97 + 0.06a 3.63 + 0.29c 3.53 + 0.76c 1.70 + 1.48c 
xEach reported value for viable count represents the mean (standard deviation) of three 
replications of the experiment 
a,b,c,dMeans with a different letter within a column differ significantly (P<0.05) 
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TABLE 8. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1 and 5 mg ml-1) 
alone or combined with phosvitin (60 mg ml-1) against Escherichia coli O157:H7 in cream of 
chicken soup held at 35 ºC for 6 hours. 
Viable count (Log10 CFU ml-1)x 
Treatment (mg 
ml-1) Hour 1 Hour 2 Hour 3 Hour 4 Hour 6 
Control 4.87 + 0.06a 5.03 + 0.12a 6.00 + 0.10a 6.80 + 0.10a 7.90 + 0.00a 
      
Phenyllactic acid 
(3.75) 3.00 + 0.56c 1.13 + 0.21c 0.00 + 0.00d 0.00 + 0.00d 0.00 + 0.00e 
      
Phenyllactic acid 
(5) 1.32 + 0.33d 0.00 + 0.00d 0.00 + 0.00d 0.00 + 0.00d 0.00 + 0.00e 
      
Phosvitin (60) 4.87 + 0.21a 5.10 + 0.10a 5.87 + 0.25a 6.17 + 0.06a 6.50 + 0.00b 
      
PLA + Phos 
 (3.75 + 60) 4.37 + 0.12ab 4.20 + 0.10b 4.17 + 0.06b 4.00 + 0.00b 4.00 + 0.00c 
      
PLA + Phos  
(5 + 60) 4.00 + 0.10b 3.67 + 0.84b 2.57 + 0.76c 2.30 + 0.87c 2.37 + 1.23d 
xEach reported value for viable count represents the mean (standard deviation) of three 
replications of the experiment 
a,b,c,d,eMeans with a different letter within a column differ significantly (P<0.05) 
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TABLE 9. Antibacterial effectiveness of phenyllactic acid (3.75 mg ml-1 and 5 mg ml-1) 
alone or combined with phosvitin (60 mg ml-1) against Staphylococcus aureus in cream of 
chicken soup held at 35 ºC for 6 hours. 
Viable count (Log10 CFU ml-1)x 
Treatment (mg  ml-
1) Hour 1 Hour 2 Hour 3 Hour 4 Hour 6 
Control 3.73 + 0.57a 4.23 + 0.57a 4.80 + 0.10a 5.90 + 0.20a 5.80 + 0.10a 
      
Phenyllactic acid 
(3.75) 0.00 + 0.00c 0.20 + 0.17c 0.00 + 0.00d 0.60 + 1.04c 0.49 + 0.50c 
      
Phenyllactic acid 
(5) 0.16 + 0.28c 1.26 + 1.12c 0.00 + 0.00d 0.70 + 0.96c 0.00 + 0.00c 
      
Phosvitin (60) 4.27 + 0.06a 4.67 + 0.06a 4.90 + 0.00a 5.53 + 0.31a 5.20 + 0.62a 
      
PLA + Phos  
(3.75 + 60) 2.43 + 0.15b 2.97 + 0.42b 3.63 + 0.31b 3.03 + 0.57b 2.33 + 0.38b 
      
PLA + Phos  
(5 + 60) 2.77 + 0.59b 2.77 + 0.87b 3.20 + 0.10c 1.60 + 1.00c 1.85 + 0.88b 
xEach reported value for viable count represents the mean (standard deviation) of three 
independent replications of the experiment 
a,b,c,dMeans with a different letter within a column differ significantly (P<0.05) 
 
 
 
 
 
 
70 
 
 
 
 
Figure 1. Growth of Listeria monocytogenes in BHI broth (35 °C) at pH 6.0 
supplemented with various concentrations of phenyllactic acid. 
 
 
 
 
 
Figure 2. Growth of Salmonella enterica in BHI broth (35 °C) at pH 6.0 supplemented 
with various concentrations of phenyllactic acid. 
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Figure 3. Growth of Escherichia coli O157:H7 in BHI broth (35 °C) at pH 6.0 
supplemented with various concentrations of phenyllactic acid. 
 
 
 
 
 
Figure 4. Growth of Staphylococcus aureus in BHI broth (35 °C) at pH 6.0 
supplemented with various concentrations of phenyllactic acid. 
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Abstract 
The objective of this research was to determine the effectiveness of phenyllactic acid (PLA) 
at three different pH values against Aspergillus ochraceus, Aspergillus spp, Penicillium 
roqueforti, Penicillium glabrum, and Penicillium spp in brain heart infusion (BHI) broth. 
Broth with added PLA (2.5 – 15 mg/ml) was inoculated with A. ochraceus, Aspergillus spp, 
P.roqueforti, P. glabrum or Penicillium spp at 106 conidia/ml. Broth without added PLA 
served as a control. Growth curves for molds (25 °C, 5 days) were developed from data 
obtained using a Bioscreen C turbidometer (OD 600 nm) which recorded optical density 
(OD) measurements every 12 hours. . At pH 3.8, PLA at 5.0 to 15 mg/ml inhibited growth of 
all five molds with stronger growth inhibition at occurring with increased PLA 
concentrations.  Compared to the aspergilli, the penicillia exhibited increased sensitivity to 
PLA at pH 3.8.  PLA at 10 or 15 mg/ml completely inhibited growth of penicillia, whereas 
only PLA at 15 mg/ml completely inhibited growth of aspergilli.  At pH 5.0 or 5.3, growth 
inhibition of molds by PLA was markedly decreased. Generally, the rate of increase in OD of 
the mold cultures was similar at all PLA concentrations tested.  Based on the results of this 
study, PLA is more effective in inhibiting the growth of molds at a lower pH (3.80).  The 
capability of PLA to effectively control the growth of several foodborne fungi at low pH 
offers new perspectives for its application as an antifungal ingredient in acidic foods that are 
prone to spoilage by molds.   
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Introduction 
A topic of discussion that is gaining a vast amount of interest is Green Consumerism 
which is a consumer-driven effort to replace synthetic additives in food products with more 
natural ingredients. This topic has gained interest because consumer demand for reduced use 
of chemical preservatives in foods has increased. Long term adverse health effects are the 
major consumer concern regarding eating food with synthetic chemical preservatives. 
Nitrites, parabens, sulfites, and sorbates are examples of chemical preservatives that 
consumers perceive as not being natural. Natural alternative replacements to synthetic 
chemical preservatives can be isolated from plant, animal, and microbial sources.  
 Mold spoilage has been a persistent problem faced by the food industry. Molds can 
grow over a wide pH range from below pH 2.0 to above pH 9.0 (Beuchat and Cousin, 2001) 
and therefore can grow in a wide variety of food products including acidic sauces, salad 
dressings and cheeses.  In order to combat mold spoilage, food preservatives such as 
potassium sorbate or sodium benzoate are used to control fungal growth in many acidic 
condiments.  Also sorbate or natamycin is use to inhibit mold growth in cheese.  
Both sodium or potassium sorbate and natamycin are antifungal agents but they also 
have unique problems. Certain species of Aspergillus and Penicillium can degrade potassium 
sorbate and produce unpleasant odors (Marth et al., 1966; Sofos and Busta, 1981; Kinderlerer 
and Hatton, 1990). On the other hand, natamycin stimulates low level resistance among fungi 
(Jay et al., 2005), and has relatively poor solubility, distribution, and stability. Also the name 
“natamycin” may give consumers the impression that an antibiotic has been added to the 
cheese as a preservative.  Considering the previously mentioned limitations in using sorbate 
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or  natamycin in cheese in addition to negative consumer perception, natural alternatives for 
control of foodborne fungi  are needed.  
 An alternative emerging new preservation technique utilizes lactic acid bacteria 
(LAB) and their metabolites. The interest in using LAB, as biopreservatives, has increased 
because LAB are Generally Recognized as Safe (GRAS) due their contribution to the healthy 
microflora of human intestinal mucosa  (Valerio et al., 2004) and their long history being 
safely consumed in fermented foods. Lactic acid bacteria are capable of producing 
antimicrobial compounds such as bacteriocins which are proteins with antibacterial activity 
that inhibit or kill bacteria (Cleveland et al., 2001). A well-known bacteriocin, Nisin, is 
produced by Lactococcus lactis and has a broad spectrum of antibacterial activity against 
gram-positive bacteria as well as GRAS status because of its ability to control the outgrowth 
and toxin production of Clostridium botulinum in pasteurized cheese spreads (Stevens et al., 
1991). The majority of identified antifungal compounds are low molecular weight 
compounds comprised of organic acids, reuterin, hydrogen peroxide, proteinaceous 
compounds, hydroxyl fatty acids and phenolic compounds (Dalie et al, 2009) but research 
has indicated that certain compounds isolated from lactic acid bacteria can have an inhibitory 
effect on either bacteria or yeasts and molds. 
 An emerging antimicrobial substance isolated from Geotrichum candidum as well as 
several Lactobacillus species is phenyllactic acid (PLA). This natural antimicrobial was 
originally used to inhibit Listeria monocytogenes in milk (Dieuleveux and Gueguen, 1998). 
More recently, lactic acid bacteria have been used to inhibit mold growth in sourdough bread. 
This has led to the discovery that Lactobacillus plantarum 21B produces PLA (Lavermicocca 
et al., 2000; Lavermicocca et al., 2003). Phenyllactic acid has  four different forms: D-3-
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phenyllactic acid, L-3-phenyllactic acid, DL-3-phenyllactic acid, and 4-hydroxyphenyllactic 
acid, all of which are produced by either Geotrichum candidum or Lactobacillus plantarum 
21D and certain other lactic acid producing bacteria (Mu et al., 2012). Limited research has 
been conducted on all four forms, but it has been found DL-3-phenyllactic acid and 4-
hydroxyphenyllactic acid have the greatest antifungal effect (Dalie et al, 2009; Lavermicocca 
et al. 2003; Lavermicocca et al. 2000). To discover the full potential of PLA, much research 
still needs to be conducted to determine its antifungal capabilities.        
 The antifungal activity of PLA may be used to improve microbial safety of foods as 
well as increase shelf life. The knowledge of natural antimicrobials is steadily increasing, but 
for this particular antimicrobial (PLA) only few published reports are available on its 
antimicrobial effectiveness against bacteria and fungi at various levels of pH. The objective 
of the present study was to evaluate the antifungal efficacy of PLA in BHI broth (25 °C) at 
three different pH values. 
Materials and Methods 
Fungal cultures and culture conditions. Aspergillus spp, Penicillium roqueforti (Blue 
cheese isolate), and Penicillium spp. were obtained from the culture collection of the 
Microbial Food Safety Laboratory, Iowa State University, Ames, IA.  Penicillium glabrum 
(ATCC 11080) and  Aspergillus ochraceus (ATCC 58722) were obtained from the American 
Type Culture Collection (Manassas, Virgina). Stock cultures were kept from (-70 °C) in 
acidified potato dextrose agar (Difco, Becton Dickinson, Sparks, Md) slants. Stock cultures 
were activated by placing 5 ml of sterile distilled water in stock cultures. Cultures were then 
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mixed by vortexing then surface-plated on acidified potato dextrose agar. Cultures were 
incubated at 25 °C for 7 days to induce the production of mold conidia.  
Preparation of inoculum. Sterile distilled water (6.0 ml) was added to the lawn growth of 
mold. A sterile stainless steel bent rod was used to make suspensions of mold conidia by 
mixing the conidia with the water added to the lawn of mold on agar surface.  The 
suspensions of conidia were used as inocula for BHI broth.  The conidial suspensions were 
serially diluted (1:10) in 0.85% (w/v) NaCl (saline) and plated on acidified potato dextrose 
agar to determine concentration (colony forming units per ml). 
Antimicrobial. A commercial preparation of DL-3-Phenyllactic acid was purchased from 
Sigma-Aldrich (P7251 Aldrich, St. Louis, Missouri). 
Preparation of treatment solutions for Bioscreen C assay. BHI broth with added PLA  (0, 
2.5, 3.75, 5, 7.5, 10, or 15 mg/ml) was filter-sterilized using 0.22 µm pore size filters (Fisher 
Scientific, Pittsburgh, PA) and the pH was adjusted to 3.8, 5.0, and 5.3 using 1M sodium 
hydroxide (NaOH) or 1M hydrochloric acid (HCl). Treatment solutions (2.5-ml samples of 
BHI broth) and the control (BHI with no added antimicrobial) were each inoculated with 25 
µl of diluted (1:100) Aspergillus ochraceus, Aspergillus spp, Penicillium roqueforti, 
Penicillium glabrum, or Penicillium spp. conidia to obtain a final concentration of 106 
conidia/broth sample.  Inoculated BHI broth was distributed in wells of a microtiter plate for 
the Bioscreen C Turbidometer. 
Bioscreen C assay. Inoculated samples (aliquots of 200 µl) were added in triplicate to the 
wells of a 100-well microtiter plate for the Bioscreen C Turbidometer (Growth Curves USA 
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Piscataway, NJ), an automated microbial growth analyzer and incubator. Microtiter plates 
were incubated in the Bioscreen C at 25 °C for 7 days and the machine took optical density 
(OD) measurements at 600 nm every 12 hours, with shaking of samples for 10 seconds prior 
to each OD reading.  
Results and Discussion 
Inhibitory effect of PLA in BHI broth at pH 3.8. The effect of PLA on the growth 
of Aspergillus ochraceus, Aspergillus spp, Penicillium roqueforti, Penicillium glabrum, and 
Penicillium spp. in BHI broth at pH 3.8 is shown in figures 1-5. At pH 3.8, PLA at 2.5 and 
3.75 mg/ml was ineffective in inhibiting the growth of Aspergillus and Penicillium molds.  
PLA concentrations ranging from 5.0 to 15 mg/ml were the most effective mold inhibitors; 
growth inhibition increased with increasing PLA concentration.  Compared to the aspergilli, 
the penicillia exhibited increased sensitivity to PLA.  PLA at 10 or 15 mg/ml completely 
inhibited growth of penicillia based on no increase in OD during 120 hours whereas, growth 
of aspergilli was completely inhibited by PLA at 15 mg/ml. 
Molds can grow over a very wide pH range (Beuchat and Cousin, 2001) and therefore 
can spoil a variety of food products.  Also, their ability to grow at low pH gives these 
organisms the advantage in being the dominant spoilage organisms in acidic foods that 
inhibit bacterial growth.  For the present study, the pH of 3.8 was chosen because it is within 
the pH range (3.68 to 4.44) of several commercial sauces and dressings including 
mayonnaise-mustard sauce (pH 3.68), thousand island dressing (pH 3.76), seafood sauce (pH 
4.38) and blue cheese dressing (pH 4.44)  (Weagant et al., 1994).  Mold growth in dressings 
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has been reported especially in dressings with large head spaces in the container or where 
improperly fitted caps increase the amount of air (Smittle, 2000). 
Our results indicate that at pH 3.8, PLA exerts a strong growth inhibitory effect 
against the five molds (Aspergillus spp and Penicillum spp) used in the present study.  These 
results are relevant to shelf-life extension of acidic foods that are susceptible to spoilage by 
fungi (yeast and molds). PLA activity (pK 3.46) has been shown to be dependent on pH, 
indicating that PLA’s mode of action is somewhat related to the lipophilic properties which 
enable the undissociated form of that antimicrobial to cross microbial membranes (Gould, 
1996).  Considering the fact that the pK of PLA is 3.46, our use of pH 3.8 would permit a 
greater availability of the undissociated form of PLA to exert an antimicrobial action against 
the molds.   
Inhibitory effect of PLA in BHI broth at pH 5.0 or 5.3. Figures 6-10 and 11-15 
show the effect of phenyllactic acid on Aspergillus ochraceus, Aspergillus spp, Penicillium 
roqueforti, Penicillium glabrum, and Penicillium spp. at pH 5.0 and 5.3, respectively.  The 
two pH values (5.0 and 5.3) used in the present study were chosen because they are within 
the pH range for several types of cheeses (pH 5.0 to 5.7).   At pH 5.0 or 5.3, the inhibitory 
action of PLA against the molds was diminished in BHI broth.  We observed that at those pH 
values, the rate of increase in OD values of the mold cultures was generally similar for 
almost all PLA concentrations and control.  This observed clustering of growth curves of the 
molds indicated that at pH 5.0 or 5.3, the ODs of mold cultures in treatment broth easily 
approached ODs of control cultures.  Schwenninger et al. (2008) reported that at pH 4.0 to 
6.0, PLA has a relatively high minimum inhibitory concentration (MIC; 50 to greater than 
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500 mM) for antifungal activity but the MIC decreased with decreasing pH.  Based on the 
results on PLA’s antifungal activity at pH 5.0 or 5.3, higher concentrations of PLA might be 
required to achieve a substantial growth inhibitory effect against molds in certain cheeses 
with pH at about 5.1 to 5.7.  Also, to circumvent the use of larger amounts of PLA and 
associated costs, consideration should be given to the combined application of lower 
concentrations of PLA with another natural antimicrobial or a “clean” technology such as 
high hydrostatic pressure to achieve microbial control. 
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Figure 1. Growth of Aspergillus ochraceus in BHI broth (25 °C) at pH 3.8 supplemented 
with various concentrations of phenyllactic acid. 
 
 
 
Figure 2. Growth of Aspergillus spp. in BHI broth (25 °C) at pH 3.8 supplemented with 
various concentrations of phenyllactic acid. 
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Figure 3. Growth of Penicillium roqueforti in BHI broth (25 °C) at pH 3.8 supplemented 
with various concentrations of phenyllactic acid. 
 
 
Figure 4. Growth of Penicillium glabrum in BHI broth (25 °C) at pH 3.8 supplemented 
with various concentrations of phenyllactic acid. 
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Figure 5. Growth of Penicillium spp. in BHI broth (25 °C) at pH 3.8 supplemented with 
various concentrations of phenyllactic acid. 
 
 
Figure 6. Growth of Aspergillus ochraceus in BHI broth (25 °C) at pH 5.0 supplemented 
with various concentrations of phenyllactic acid. 
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Figure 7. Growth of Aspergillus spp. in BHI broth (25 °C) at pH 5.0 supplemented with 
various concentrations of phenyllactic acid. 
 
 
Figure 8. Growth of Penicillium roqueforti in BHI broth (25 °C) at pH 5.0 supplemented 
with various concentrations of phenyllactic acid. 
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Figure 9. Growth of Penicillium glabrum in BHI broth (25 °C) at pH 5.0 supplemented 
with various concentrations of phenyllactic acid. 
 
Figure 10. Growth of Penicillium spp. in BHI broth (25 °C) at pH 5.0 supplemented 
with various concentrations of phenyllactic acid. 
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Figure 11. Growth of Aspergillus ochraceus in BHI broth (25 °C) at pH 5.3 
supplemented with various concentrations of phenyllactic acid. 
 
Figure 12. Growth of Aspergillus spp. in BHI broth (25 °C) at pH 5.3 supplemented with 
various concentrations of phenyllactic acid. 
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Figure 13. Growth of Penicillium roqueforti in BHI broth (25 °C) at pH 5.3 
supplemented with various concentrations of phenyllactic acid. 
 
Figure 14. Growth of Penicillium glabrum in BHI broth (25 °C) at pH 5.3 supplemented 
with various concentrations of phenyllactic acid. 
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Figure 15. Growth of Penicillium spp. in BHI broth (25 °C) at pH 5.3 supplemented 
with various concentrations of phenyllactic acid. 
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CHAPTER 5. GENERAL CONCLUSIONS 
 Bacterial pathogens and molds in food and beverage products pose a huge food safety 
risk to consumers because they can cause foodborne illnesses due to infection or intoxication. 
Antimicrobials derived from natural sources such as plant, animal, or microbial sources are 
gaining much consumer interest because of the increased demand for more “natural” 
ingredients in food products. 
 The present research indicated that the naturally produced antimicrobial phenyllactic 
acid alone is strongly inhibitory to Listeria monocytogenes, Salmonella enterica, 
Staphylococcus aureus, and Escherichia coli O157:H7 in laboratory broth and in cream of 
chicken soup that was held under temperature-abuse conditions (12 °C and 35 °C). 
Phenyllactic acid (5 mg ml-1) proved to be the most effective treatment at controlling the 
bacterial pathogens used in this study as it exhibited a bactericidal effect on all pathogens 
tested in the present study.  
 Phenyllactic acid combined with phosvitin (60 mg ml-1) does not offer any 
significant effect compared to phenyllactic acid used alone against Gram-positive and Gram 
negative bacterial pathogens in cream of chicken soup stored at 12 °C or 35 °C. Phenyllactic 
acid combined with phosvitin (60 mg ml-1) had a very minimal antimicrobial effect against 
foodborne pathogens. Phenyllactic acid in laboratory broth has a greater effect against molds 
in acidic pH (pH 3.8) compared to pH 5.0 or 5.3.  Further research is needed to address the 
possibility of combining phenyllactic acid with other hurdle technology techniques such as 
high hydrostatic pressure or other natural antimicrobials for control of foodborne pathogens 
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and spoilage microorganisms.  Also the impact of phenyllactic acid on the sensory 
characteristics of food products warrants investigation. 
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APPENDIX A. 
GRAPHS: EFFECT OF PLA ON PATHOGEN GROWTH IN BHI BROTH AT PH 7.2 
Figure 5. Growth of Listeria monocytogenes in BHI broth (35 °C) at pH 7.2 
supplemented with various concentrations of phenyllactic acid. 
 
Figure 6. Growth of Salmonella enterica in BHI broth (35 °C) at pH 7.2 supplemented 
with various concentrations of phenyllactic acid. 
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Figure 7. Growth of Escherichia coli O157:H7 in BHI broth (35 °C) at pH 7.2 
supplemented with various concentrations of phenyllactic acid. 
 
 
 
Figure 8. Growth of Staphylococcus aureus in BHI broth (35 °C) at pH 7.2 
supplemented with various concentrations of phenyllactic acid. 
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APPENDIX B. 
TABLE: INITIAL PH AND WATER ACTIVITY VALUES OF THE SOUP 
 
TABLE 10. Initial pH and water activity of cream of chicken soup (23 ± 1 °C) with or 
without added antimicrobials. 
Treatment code Treatment Description pH Water Activity (aw) 
CTRL Control (no treatments 
added) 5.85 + 0.14a 0.988 + 0.00 
PLA 3.75 Phenyllactic acid (3.75 mg 
ml-1) 3.66 + 0.17f 0.987 + 0.00 
PLA 5 
Phenyllactic acid (5.0 mg 
ml-1) 3.34 + 0.04e 0.987 + 0.00 
PHOS Phosvitin (60 mg ml-1) 5.33 + 0.11b 0.988 + 0.00 
PLA 3.75 + PHOS 
Phenyllactic acid (3.75 mg 
ml-1) + Phosvitin (60 mg 
ml-1) 
4.83 + 0.06c 0.986 + 0.00 
PLA 5.0 + PHOS 
Phenyllactic acid (5.0 mg 
ml-1) + Phosvitin (60 mg 
ml-1) 
4.57 + 0.03d 0.986 + 0.00 
xEach reported value for viable count represents the mean (standard deviation) of three  
replications of the experiment 
a,b,c,d,e,fMeans with a different letter within a column differ significantly (P<0.05) 
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